Advanced search
Publication Cover
Journal of Toxicology and Environmental Health, Part B
Critical Reviews
Volume 16, 2013 - Issue 7
Submit an article Journal homepage
47,691
Views
93
CrossRef citations to date
0
Altmetric
Original Articles

Sucralose, A Synthetic Organochlorine Sweetener: Overview Of Biological Issues

Susan S. Schiffman Department of Electrical and Computer Engineering, College of Engineering, North Carolina State University, Raleigh, North Carolina, USACorrespondence[email protected]
&
Kristina I. Rother Section on Pediatric Diabetes & Metabolism, Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, Maryland, USA
Pages 399-451 | Published online: 12 Nov 2013

REFERENCES

  • Abou-Donia , M. B. and Menzel , D. B. 1968a . Chick microsomal oxidases. Isolation, properties, and stimulation by embryonic exposure to 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane . Biochemistry , 7 : 3788 – 3794 .
  • Abou-Donia , M. B. and Menzel , D. B. 1968b . The metabolism in vivo of 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (DDT), 1,1-dichloro-2,2-bis(p-chlorophenyl)ethane (DDD) and 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (DDE) in the chick by embryonic injection and dietary ingestion . Biochem. Pharmacol , 17 : 2143 – 2161 .
  • Abou-Donia , M. B. , El-Masry , E. M. , Abdel-Rahman , A. A. , McLendon , R. E. and Schiffman , S. S. 2008 . Splenda alters gut microflora and increases intestinal P-glycoprotein and cytochrome P-450 in male rats . J. Toxicol. Environ. Health A , 71 : 1415 – 1429 .
  • Abu-Qare , A. W. , Elmasry , E. and Abou-Donia , M. B. 2003 . A role for P-glycoprotein in environmental toxicology . J. Toxicol. Environ. Health B , 6: : 279 – 288 .
  • Adachi , Y. , Suzuki , H. and Sugiyama , Y. 2001 . Comparative studies on in vitro methods for evaluating in vivo function of MDR1 P-glycoprotein . Pharm. Res , 18 : 1660 – 1668 .
  • Adas , F. , Berthou , F. , Picart , D. , Lozac'h , P. , Beaugé , F. and Amet , Y. 1998 . Involvement of cytochrome P450 2E1 in the (ω-1)-hydroxylation of oleic acid in human and rat liver microsomes . J. Lipid Res , 39 : 1210 – 1219 .
  • Aiba , T. , Takehara , Y. , Okuno , M. and Hashimoto , Y. 2003 . Poor correlation between intestinal and hepatic metabolic rates of CYP3A4 substrates in rats . Pharm. Res , 20 : 745 – 748 .
  • Albert , M. J. , Mathan , V. I. and Baker , S. J. 1980 . Vitamin B12 synthesis by human small intestinal bacteria . Nature , 283 : 781 – 782 .
  • Anderson , E. S. 1975 . The problem and implications of chloramphenicol resistance in the typhoid bacillus . J. Hyg. (Lond) , 74 : 289 – 299 .
  • Anderson , G. H. , Catherine , N. L. , Woodend , D. M. and Wolever , T. M. 2002 . Inverse association between the effect of carbohydrates on blood glucose and subsequent short-term food intake in young men . Am. J. Clin. Nutr , 76 : 1023 – 1030 .
  • Anderson , M. , Opawale , F. , Rao , M. , Delmarre , D. and Anyarambhatla , G. 2006 . “ Excipients for oral liquid formulations ” . In Excipient development for pharmaceutical biotechnology, and drug delivery systems , Edited by: Katdare , A. and Chaubal , M. V. 155 – 180 . New York , NY : Informa Healthcare USA . Ined.
  • Anway , M. D. , Cupp , A. S. , Uzumcu , M. and Skinner , M. K. 2005 . Epigenetic transgenerational actions of endocrine disruptors and male fertility . Science , 308 : 1466 – 1469 .
  • Aronson , K. J. , Miller , A. B. , Woolcott , C. G. , Sterns , E. E. , McCready , D. R. , Lickley , L. A. , Fish , E. B. , Hiraki , G. Y. , Holloway , C. , Ross , T. , Hanna , W. M. , SenGupta , S. K. and Weber , J. P. 2000 . Breast adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer risk . Cancer Epidemiol. Biomarkers Prev , 9 : 55 – 63 .
  • Backman , J. T. , Olkkola , K. T. and Neuvonen , P. J. 1996 . Rifampin drastically reduces plasma concentrations and effects of oral midazolam . Clin. Pharmacol. Ther , 59 : 7 – 13 .
  • Bae , W. , Mehra , R. K. , Mulchandani , A. and Chen , W. 2001 . Genetic engineering of Escherichia coli for enhanced uptake and bioaccumulation of mercury . Appl. Environ Microbiol , 67 : 5335 – 5338 .
  • Bain , L. J. and LeBlanc , G. A. 1996 . Interaction of structurally diverse pesticides with the human MDR1 gene product P-glycoprotein . Toxicol. Appl. Pharmacol , 141 : 288 – 298 .
  • Baird , I. M. , Shephard , N. W. , Merritt , R. J. and Hildick-Smith , G. 2000 . Repeated dose study of sucralose tolerance in human subjects . Food Chem. Toxicol , 38 ( suppl. 2 ) : S123 – S129 .
  • Bannach , G. , Almeida , R. R. , Lacerda , L. G. , Schnitzler , E. and Ionashiro , M. 2009 . Thermal stability and thermal decomposition of sucralose . Ecl. Quím. São Paulo , 34 : 21 – 26 .
  • Bapiro , T. E. , Egnell , A. C. , Hasler , J. A. and Masimirembwa , C. M. 2001 . Application of higher throughput screening (HTS) inhibition assays to evaluate the interaction of antiparasitic drugs with cytochrome P450s . Drug Metab. Dispos , 29 : 30 – 35 .
  • Barndt , R. L. and Jackson , G. 1990 . Stability of sucralose in baked goods . Food Technol , 44 (Jan) : 62 – 66 .
  • Bauer , S. , Störmer , E. , Johne , A. , Krüger , H. , Budde , K. , Neumayer , H. H. , Roots , I. and Mai , I. 2003 . Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients . Br. J. Clin. Pharmacol , 55 : 203 – 211 .
  • Bauer , T. M. 1998 . “ The role of gut bacteria in drug metabolism ” . In Gut and the liver , Edited by: Blum , H. E. , Bode , C. , Bode , J. C. and Sartor , R. B. 177 – 184 . Hingham , MA : Kluwer Academic . Ined.
  • Baumhäkel , M. , Kasel , D. , Rao-Schymanski , R. A. , Böcker , R. , Beckurts , K. T. , Zaigler , M. , Barthold , D. and Fuhr , U. 2001 . Screening for inhibitory effects of antineoplastic agents on CYP3A4 in human microsomes . Int. J. Clin. Pharmacol. Ther , 39 : 517 – 528 .
  • Baune , B. , Flinois , J. P. , Furlan , V. , Gimenez , F. , Taburet , A. M. , Becquemont , L. and Farinotti , R. 1999 . Halofantrine metabolism in microsomes in man: Major role of CYP 3A4 and CYP 3A5 . J. Pharm. Pharmacol , 51 : 419 – 426 .
  • Becquemont , L. , Mouajjah , S. , Escaffre , O. , Beaune , P. , Funck-Brentano , C. and Jaillon , P. 1999 . Cytochrome P-450 3A4 and 2C8 are involved in zopiclone metabolism . Drug Metab. Dispos , 27 : 1068 – 1073 .
  • Benet , L. Z. , Izumi , T. , Zhang , Y. , Silverman , J. A. and Wacher , V. J. 1999 . Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery . J. Control Release , 62 : 25 – 31 .
  • Benet , L. Z. 2009 . The drug transporter-metabolism alliance: Uncovering and defining the interplay . Mol. Pharm , 6 : 1631 – 1643 .
  • Bennett , C. , Dordick , J. S. , Hacking , A. J. and Cheetham , P. S. J. 1992 . Biocatalytic synthesis of disaccharide high-intensity sweetener sucralose via a tetrachlororaffinose intermediate . Biotechnol. Bioeng , 39 : 211 – 217 .
  • Beringer , P. M. and Slaughter , R. L. 2005 . Transporters and their impact on drug disposition . Ann. Pharmacother , 39 : 1097 – 1108 .
  • Berson , A. , Descatoire , V. , Sutton , A. , Fau , D. , Maulny , B. , Vadrot , N. , Feldmann , G. , Berthon , B. , Tordjmann , T. and Pessayre , D. 2001 . Toxicity of alpidem, a peripheral benzodiazepine receptor ligand, but not zolpidem, in rat hepatocytes: Role of mitochondrial permeability transition and metabolic activation . J. Pharmacol. Exp. Ther , 299 : 793 – 800 .
  • Berthou , F. , Dreano , Y. , Belloc , C. , Kangas , L. , Gautier , J. C. and Beaune , P. 1994 . Involvement of cytochrome P450 3A enzyme family in the major metabolic pathways of toremifene in human liver microsomes . Biochem. Pharmacol , 47 : 1883 – 1895 .
  • Bertilsson , L. , Höjer , B. , Tybring , G. , Osterloh , J. and Rane , A. 1980 . Autoinduction of carbamazepine metabolism in children examined by a stable isotope technique . Clin. Pharmacol. Ther , 27 : 83 – 88 .
  • Bertilsson , L. , Tomson , T. and Tybring , G. 1986 . Pharmacokinetics: Time-dependent changes—Autoinduction of carbamazepine epoxidation . J. Clin. Pharmacol , 26 : 459 – 462 .
  • Biles , R. W. and Piper , C. E. 1983 . Mutagenicity of chloropropanol in a genetic screening battery . Fundam. Appl. Toxicol , 3 : 27 – 33 .
  • Birnbaum , L. S. 2013 . When environmental chemicals act like uncontrolled medicine . Trends Endocrinol. Metab , 24 : 321 – 323 .
  • Björkholm , B. , Bok , C. M. , Lundin , A. , Rafter , J. , Hibberd , M. L. and Pettersson , S. 2009 . Intestinal microbiota regulate xenobiotic metabolism in the liver . PLoS One , 4 : e6958
  • Blaser , M. J. and Falkow , S. 2009 . What are the consequences of the disappearing human microbiota? . Nat. Rev. Microbiol , 7 : 887 – 894 .
  • Bogaards , J. J. , van Ommen , B. , Wolf , C. R. and van Bladeren , P. J. 1995 . Human cytochrome P450 enzyme selectivities in the oxidation of chlorinated benzenes . Toxicol. Appl. Pharmacol , 132 : 44 – 52 .
  • Bonnet , U. 2003 . Moclobemide: Therapeutic use and clinical studies . CNS Drug Rev , 9 : 97 – 140 .
  • Booth , D. A. 1994 . Psychology of nutrition , 56 – 57 . London , UK : Taylor & Francis .
  • Borchers , A. T. , Selmi , C. , Meyers , F. J. , Keen , C. L. and Gershwin , M. E. 2009 . Probiotics and immunity . J. Gastroenterol , 44 : 26 – 46 .
  • Bort , R. , Macé , K. , Boobis , A. , Gómez-Lechón , M. J. , Pfeifer , A. and Castell , J. 1999 . Hepatic metabolism of diclofenac: Role of human CYP in the minor oxidative pathways . Biochem. Pharmacol , 58 : 787 – 796 .
  • Bort , R. , Ponsoda , X. , Carrasco , E. , Gómez-Lechón , M. J. and Castell , J. V. 1996 . Metabolism of aceclofenac in humans . Drug Metab. Dispos , 24 : 834 – 841 .
  • Boulton , D. W. , DeVane , C. L. , Liston , H. L. and Markowitz , J. S. 2002 . In vitro P-glycoprotein affinity for atypical and conventional antipsychotics . Life Sci , 71 : 163 – 169 .
  • Brannan , M. D. , Affrime , M. B. , Radwanski , E. , Cayen , M. N. and Banfield , C. 1995 . “ Effects of various cytochrome P450 inhibitors on the metabolism of loratadine ” . In Clin. Pharmacol. Ther Vol. 57 , 193 OII-A-4
  • Brown , A. W. , Bohan Brown , M. M. , Onken , K. L. and Beitz , D. C. 2011 . Short-term consumption of sucralose, a nonnutritive sweetener, is similar to water with regard to select markers of hunger signaling and short-term glucose homeostasis in women . Nutr. Res , 31 : 882 – 888 .
  • Brown , R. J. and Rother , K. I. 2012 . Non-nutritive sweeteners and their role in the gastrointestinal tract . J. Clin. Endocrinol. Metab , 97 : 2597 – 2605 .
  • Brown , R. J. , Walter , M. and Rother , K. I. 2009 . Ingestion of diet soda before a glucose load augments glucagon-like peptide-1 secretion . Diabetes Care , 32 : 2184 – 2186 .
  • Brown , R. J. , Walter , M. and Rother , K. I. 2012 . Effects of diet soda on gut hormones in youths with diabetes . Diabetes Care , 35 : 959 – 964 .
  • Brownlee , K. A. 1960 . Statistical theory and methodology in science and engineering , New York , NY : John Wiley & Sons .
  • Brusick , D. , Borzelleca , J. F. , Gallo , M. , Williams , G. , Kille , J. , Hayes , A. W. , Pi-Sunyer , F. X. , Williams , C. and Burks , W. 2009 . “ Expert panel report on a study of Splenda in male rats ” . In Regul. Toxicol. Pharmacol Vol. 55 , 6 – 12 .
  • Bruyère , A. , Declevès , X. , Bouzom , F. , Proust , L. , Martinet , M. , Walther , B. and Parmentier , Y. 2009 . Development of an optimized procedure for the preparation of rat intestinal microsomes: Comparison of hepatic and intestinal microsomal cytochrome P450 enzyme activities in two rat strains . Xenobiotica , 39 : 22 – 32 .
  • Burdge , G. C. , Hanson , M. A. , Slater-Jefferies , J. L. and Lillycrop , K. A. 2007 . Epigenetic regulation of transcription: A mechanism for inducing variations in phenotype (fetal programming) by differences in nutrition during early life? . Br. J. Nutr , 97 : 1036 – 1046 .
  • Cabrini , L. , Landi , L. , Stefanelli , C. , Barzanti , V. and Sechi , A.M. 1992 . Extraction of lipids and lipophilic antioxidants from fish tissues: A comparison among different methods . Comp. Biochem. Physiol. Part B , 101 : 383 – 386 .
  • Calafat , A. M. , Ye , X. , Wong , L. Y. , Reidy , J. A. and Needham , L. L. 2008 . Urinary concentrations of triclosan in the U.S. population: 2003–2004 . Environ. Health Perspect , 116 : 303 – 307 .
  • Chadwick , R. W. , Cooper , R. L. , Chang , J. , Rehnberg , G. L. and McElroy , W. K. 1988 . Possible antiestrogenic activity of lindane in female rats . J. Biochem. Toxicol , 3 : 147 – 158 .
  • Chang , T. K. , Yu , L. , Maurel , P. and Waxman , D. J. 1997 . Enhanced cyclophosphamide and ifosfamide activation in primary human hepatocyte cultures: Response to cytochrome P-450 inducers and autoinduction by oxazaphosphorines . Cancer Res , 57 : 1946 – 1954 .
  • Chen , C. , Hanson , E. , Watson , J. W. and Lee , J. S. 2003a . P-glycoprotein limits the brain penetration of nonsedating but not sedating H1-antagonists . Drug Metab. Dispos , 31 : 312 – 318 .
  • Chen , C. , Staudinger , J. L. and Klaassen , C. D. 2003b . Nuclear receptor, pregname X receptor, is required for induction of UDP-glucuronosyltranferases in mouse liver by pregnenolone-16 alpha-carbonitrile . Drug Metab. Dispos , 31 : 908 – 915 .
  • Chen , J. and Raymond , K. 2006 . Roles of rifampicin in drug–drug interactions: Underlying molecular mechanisms involving the nuclear pregnane X receptor . Ann. Clin. Microbiol. Antimicrob , 5 : 3
  • Chen , Y. , Tang , Y. , Guo , C. , Wang , J. , Boral , D. and Nie , D. 2012 . Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters . Biochem. Pharmacol , 83 : 1112 – 1126 .
  • Cho , I. and Blaser , M. J. 2012 . The human microbiome: At the interface of health and disease . Nat. Rev. Genet , 13 : 260 – 270 .
  • Cho , W. S. , Han , B. S. , Lee , H. , Kim , C. , Nam , K. T. , Park , K. , Choi , M. , Kim , S. J. , Kim , S. H. , Jeong , J. and Jang , D. D. 2008 . Subchronic toxicity study of 3-monochloropropane-1,2-diol administered by drinking water to B6C3F1 mice . Food Chem. Toxicol , 46 : 1666 – 1673 .
  • Chonan , O. , Takahashi , R. and Watanuki , M. 2001 . Role of activity of gastrointestinal microflora in absorption of calcium and magnesium in rats fed ß1-4 linked galactooligosaccharides . Biosci. Biotechnol. Biochem , 65 : 1872 – 1875 .
  • Choo , E. F. , Leake , B. , Wandel , C. , Imamura , H. , Wood , A. J. , Wilkinson , G. R. and Kim , R. B. 2000 . Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes . Drug Metab. Dispos , 28 : 655 – 660 .
  • Cizza , G. and Rother , K. I. 2012 . Beyond fast food and slow motion: Weighty contributors to the obesity epidemic . J. Endocrinol. Invest , 35 : 236 – 242 .
  • Claus , S. P. , Tsang , T. M. , Wang , Y. , Cloarec , O. , Skordi , E. , Martin , F. P. , Rezzi , S. , Ross , A. , Kochhar , S. , Holmes , E. and Nicholson , J. K. 2008 . Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes . Mol. Syst. Biol , 4 : 219
  • Clement , B. and Demesmaeker , M. 1997 . Formation of guanoxabenz from guanabenz in human liver. A new metabolic marker for CYP1A2 . Drug Metab. Dispos , 25 : 1266 – 1271 .
  • Clemente , J. C. , Ursell , L. K. , Parfrey , L. W. and Knight , R. 2012 . The impact of the gut microbiota on human health: An integrative view . Cell , 148 : 1258 – 1270 .
  • Colditz , G. A. , Willett , W. C. , Stampfer , M. J. , London , S. J. , Segal , M. R. and Speizer , F. E. 1990 . Patterns of weight change and their relation to diet in a cohort of healthy women . Am. J. Clin. Nutr , 51 : 1100 – 1105 .
  • Coleman , S. , Linderman , R. , Hodgson , E. and Rose , R. L. 2000 . Comparative metabolism of chloroacetamide herbicides and selected metabolites in human and rat liver microsomes . Environ. Health Perspect , 108 : 1151 – 1157 .
  • Corkey , B. E. 2012 . Banting lecture 2011: Hyperinsulinemia: Cause or consequence? . Diabetes , 61 : 4 – 13 .
  • Coumoul , X. , Diry , M. and Barouki , R. 2002 . PXR-dependent induction of human CYP3A4 gene expression by organochlorine pesticides . Biochem. Pharmacol , 64 : 1513 – 1519 .
  • Crabbe , E. , Nolasco-Hipolito , C. , Kobayashi , G. , Sonomoto , K. and Ishizaki , A. 2001 . Biodiesel production from crude palm oil and evaluation of butanol extraction and fuel properties . Process Biochem , 37 : 65 – 71 .
  • Cummings , J. H. and Macfarlane , G. T. 1991 . The control and consequences of bacterial fermentation in the human colon . J. Appl. Bacteriol , 70 : 443 – 459 .
  • Cummings , J. H. and Macfarlane , G. T. 1997 . Role of intestinal bacteria in nutrient metabolism . J. Parenter. Enteral. Nutr , 21 : 357 – 365 .
  • Custodio , J. M. , Wu , C. Y. and Benet , L. Z. 2008 . Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption . Adv. Drug Deliv. Rev , 60 : 717 – 733 .
  • Dantzig , A. H. , Shepard , R. L. , Law , K. L. , Tabas , L. , Pratt , S. , Gillespie , J. S. , Binkley , S. N. , Kuhfeld , M. T. , Starling , J. J. and Wrighton , S. A. 1999 . Selectivity of the multidrug resistance modulator, LY335979, for P-glycoprotein and effect on cytochrome P-450 activities . J. Pharmacol. Exp. Ther , 290 : 854 – 862 .
  • Davies , E. 2010 . Sweets for my sweet . Chem. World , 7 : 46 – 49 .
  • Decherf , S. and Demeneix , B. A. 2011 . The obesogen hypothesis: A shift of focus from the periphery to the hypothalamus . J. Toxicol. Environ. Health B , 14 : 423 – 448 .
  • Deichmann , W. B. , MacDonald , W. E. , Cubit , D. A. and Beasley , A. G. 1972 . Effects of starvation in rats with elevated DDT and dieldrin tissue levels . Int. Arch. Arbeitsmed , 29 : 233 – 252 .
  • Dekant , W. , Assmann , M. and Urban , G. 1995 . The role of cytochrome P450 2E1 in the species-dependent biotransformation of 1,2-dichloro-1,1,2-trifluoroethane in rats and mice . Toxicol. Appl. Pharmacol , 135 : 200 – 207 .
  • de Ruyter , J. C. , Olthof , M. R. , Seidell , J. C. and Katan , M. B. 2012 . A trial of sugar-free or sugar-sweetened beverages and body weight in children . N. Engl. J Med , 367 : 1397 – 1406 .
  • Desta , Z. , Soukhova , N. , Mahal , S. K. and Flockhart , D. A. 2000 . Interaction of cisapride with the human cytochrome P450 system: Metabolism and inhibition studies . Drug Metab. Dispos , 28 : 789 – 800 .
  • Desta , Z. , Wu , C. M. , Morocho , A. M. and Flockhart , D. A . 2002 . The gastroprokinetic and antiemetic drug metoclopramide is a substrate and inhibitor of cytochrome P450 2D6 . Drug Metab. Dispos , 30 : 336 – 343 .
  • Dhingra , R. , Sullivan , L. , Jacques , P. F. , Wang , T. J. , Fox , C. S. , Meigs , J. B. , D'Agostino , R. B. , Gaziano , J. M. and Vasan , R. S. 2007 . Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community . Circulation , 116 : 480 – 488 .
  • Dong , S. , Wu , J. , Liu , G. , Zhang , B. and Zheng , M. 2011 . Unintentionally produced dioxin-like polychlorinated biphenyls during cooking . Food Control , 22 : 1797 – 1802 .
  • Dong , S. , Liu , G. , Zhang , B. , Gao , L. and Zheng , M. 2013 . Formation of polychlorinated naphthalenes during the heating of cooking oil in the presence of high amounts of sucralose . Food Control , 32 : 1 – 5 .
  • Doran , A. , Obach , R. S. , Smith , B. J. , Hosea , N. A. , Becker , S. , Callegari , E. , Chen , C. , Chen , X. , Choo , E. , Cianfrogna , J. , Cox , L. M. , Gibbs , J. P. , Gibbs , M. A. , Hatch , H. , Hop , C. E. , Kasman , I. N. , Laperle , J. , Liu , J. , Liu , X. , Logman , M. , Maclin , D. , Nedza , F. M. , Nelson , F. , Olson , E. , Rahematpura , S. , Raunig , D. , Rogers , S. , Schmidt , K. , Spracklin , D. K. , Szewc , M. , Troutman , M. , Tseng , E. , Tu , M. , Van Deusen , J. W. , Venkatakrishnan , K. , Walens , G. , Wang , E. Q. , Wong , D. , Yasgar , A. S. and Zhang , C. 2005 . The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: Evaluation using the MDR1A/1B knockout mouse model . Drug Metab. Dispos , 33 : 165 – 174 .
  • Draper , A. J. , Madan , A. and Parkinson , A. 1997 . Inhibition of coumarin 7-hydroxylase activity in human liver microsomes . Arch. Biochem. Biophys , 341 : 47 – 61 .
  • Drescher , S. , Glaeser , H. , Mürdter , T. , Hitzl , M. , Eichelbaum , M. and Fromm , M. F. 2003 . P-glycoprotein-mediated intestinal and biliary digoxin transport in humans . Clin. Pharmacol. Ther , 73 : 223 – 231 .
  • Dresser , G. K. , Schwarz , U. I. , Wilkinson , G. R. and Kim , R. B. 2003 . Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects . Clin. Pharmacol. Ther , 73 : 41 – 50 .
  • DuBois , G. E. 2011 . Validity of early indirect models of taste active sites and advances in new taste technologies enabled by improved models . Flav. Fragr. J , 26 : 239 – 253 .
  • DuBois , G. E. and Prakash , I. 2012 . Non-caloric sweeteners, sweetness modulators, and sweetener enhancers . Annu. Rev. Food Sci. Technol , 3 : 353 – 380 .
  • DuBois , G. E. , Walters , D. E. , Schiffman , S. S. , Warwick , Z. S. , Booth , B. J. , Pecore , S. D. , Gibes , K. , Carr , B. T. and Brands , L. M. 1991 . “ Concentration-response relationships of sweeteners: A systematic study ” . In Sweeteners. Discovery, molecular design, and chemoreception, ACS Symposium Series 450 , Edited by: Walters , D. E. , Orthoefer , F. T. and DuBois , G. E. 261 – 276 . Washington , DC : American Chemical Society . Ined.
  • Duncan , S. H. , Belenguer , A. , Holtrop , G. , Johnstone , A. M. , Flint , H. J. and Lobley , G. E. 2007 . Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces . Appl. Environ. Microbiol , 73 : 1073 – 1078 .
  • Dürr , D. , Stieger , B. , Kullak-Ublick , G. A. , Rentsch , K. M. , Steinert , H. C. , Meier , P. J. and Fattinger , K. 2000 . St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4 . Clin. Pharmacol. Ther , 68 : 598 – 604 .
  • Ebbeling , C. B. , Feldman , H. A. , Chomitz , V. R. , Antonelli , T. A. , Gortmaker , S. L. , Osganian , S. K. and Ludwig , D. S. 2012 . A randomized trial of sugar-sweetened beverages and adolescent body weight . N. Engl. J. Med , 367 : 1407 – 1416 .
  • 2011 . “ EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF) of the European Food Safety Authority ” . In Scientific Opinion on Flavouring Group Evaluation 301 (FGE.301): A sulphur substituted pyrimidin-derivative and its hydrochloride salt from Chemical Group 30. EFSA J Vol. 9 , 28 1994[pp.]
  • Ehrhardt , M. , Lindenmaier , H. , Burhenne , J. , Haefeli , W. E. and Weiss , J. 2004 . Influence of lipid lowering fibrates on P-glycoprotein activity in vitro . Biochem. Pharmacol , 67 : 285 – 292 .
  • Ekins , S. , Kim , R. B. , Leake , B. F. , Dantzig , A. H. , Schuetz , E. G. , Lan , L. B. , Yasuda , K. , Shepard , R. L. , Winter , M. A. , Schuetz , J. D. , Wikel , J. H. and Wrighton , S. A. 2002 . Three-dimensional quantitative structure–activity relationships of inhibitors of P-glycoprotein . Mol. Pharmacol , 61 : 964 – 973 .
  • Endicott , J. A. and Ling , V. 1989 . The biochemistry of P-glycoprotein-mediated multidrug resistance . Annu. Rev. Biochem , 58 : 137 – 171 .
  • Endres , C. J. , Hsiao , P. , Chung , F. S. and Unadkat , J. D. 2006 . The role of transporters in drug interactions . Eur. J. Pharm. Sci , 27 : 501 – 517 .
  • European Union. 2004. Directive 2003/115/EC of the European Parliament and of the Council of 22 December 2003 amending Directive 94/35/EC on sweeteners for use in foodstuffs. Off. J. Eur. Union 47 (L24), 65–71.accessed February 6, 2013 http://eur-lex.europa.eu/JOHtml.do?uri=OJ: L:2004:024: SOM: en: HTML (http://eur-lex.europa.eu/JOHtml.do?uri=OJ: L:2004:024: SOM: en: HTML)
  • Faassen , F. , Vogel , G. , Spanings , H. and Vromans , H. 2003 . Caco-2 permeability, P-glycoprotein transport ratios and brain penetration of heterocyclic drugs . Int. J. Pharm , 263 : 113 – 122 .
  • Fang , H. M. , Xu , J. M. , Mei , Q. , Diao , L. , Chen , M. L. , Jin , J. and Xu , X. H. 2009 . Involvement of cytochrome P450 3A4 and P-glycoprotein in first-pass intestinal extraction of omeprazole in rabbits . Acta Pharmacol. Sin , 30 : 1566 – 1572 .
  • Faucette , S. R. , Hawke , R. L. , Lecluyse , E. L. , Shord , S. S. , Yan , B. , Laethem , R. M. and Lindley , C. M. 2000 . Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity . Drug Metab. Dispos , 28 : 1222 – 1230 .
  • Faucette , S. R. , Wang , H. , Hamilton , G. A. , Jolley , S. L. , Gilbert , D. , Lindley , C. , Yan , B. , Negishi , M. and LeCluyse , E. L. 2004 . Regulation of CYP2B6 in primary human hepatocytes by prototypical inducers . Drug Metab. Dispos , 32 : 348 – 358 .
  • Feil , R. and Fraga , M. F. 2012 . Epigenetics and the environment: Emerging patterns and implications . Nat. Rev. Genet , 13 : 97 – 109 .
  • Felmlee , M. A. , Lon , H. K. , Gonzalez , F. J. and Yu , A. M. 2008 . Cytochrome P450 expression and regulation in CYP3A4/CYP2D6 double transgenic humanized mice . Drug Metab. Dispos , 36 : 435 – 441 .
  • Finn , J. P. and Lord , G. H. 2000 . Neurotoxicity studies on sucralose and its hydrolysis products with special reference to histopathologic and ultrastructural changes . Food Chem. Toxicol , 38 ( suppl. 2 ) : S7 – S17 .
  • Flaherty , K. T. , Lathia , C. , Frye , R. F. , Schuchter , L. , Redlinger , M. , Rosen , M. and O'Dwyer , P. J. 2011 . Interaction of sorafenib and cytochrome P450 isoenzymes in patients with advanced melanoma: A phase I/II pharmacokinetic interaction study . Cancer Chemother. Pharmacol , 68 : 1111 – 1118 .
  • Flockhart, D. A. 2013. Drug interactions: Cytochrome P450 drug interaction table. Indiana University School of Medicineaccessed February 6, 2013 http://medicine.iupui.edu/clinpharm/ddis/table.asp (http://medicine.iupui.edu/clinpharm/ddis/table.asp)
  • Fooks , L. J. and Gibson , G. R. 2002 . Probiotics as modulators of the gut flora . Br. J. Nutr. , 88 ( suppl. 1 ) : S39 – S49 .
  • Ford , H. E. , Peters , V. , Martin. , N. M. , Sleeth. , M. L. , Ghatei , M. A. , Frost , G. S. and Bloom. , S. R. 2011 . Effects of oral ingestion of sucralose on gut hormone response and appetite in healthy normal-weight subjects . Eur. J. Clin. Nutr , 65 : 508 – 513 .
  • Fowler , S. P. , Williams , K. , Resendez , R. G. , Hunt , K. J. , Hazuda , H. P. and Stern , M. P. 2008 . Fueling the obesity epidemic? Artificially sweetened beverage use and long-term weight gain . Obesity , 16 : 1894 – 1900 .
  • Frank , G. K. , Oberndorfer , T. A. , Simmons , A. N. , Paulus , M. P. , Fudge , J. L. , Yang , T. T. and Kaye , W. H. 2008 . Sucrose activates human taste pathways differently from artificial sweetener . Neuroimage , 39 : 1559 – 1569 .
  • Fraud , S. , Maillard , J. Y. and Russell , A. D. 2001 . Comparison of the mycobactericidal activity of ortho-phthalaldehyde, glutaraldehyde and other dialdehydes by a quantitative suspension test . J. Hosp. Infect , 48 : 214 – 221 .
  • Freeman , J. S. 2009 . Role of the incretin pathway in the pathogenesis of type 2 diabetes mellitus . Cleve. Clin. J. Med. , 76 ( suppl. 5 ) : S12 – S19 .
  • Fujita , Y , Wideman , R. D. , Speck , M. , Asadi , A. , King , D. S. , Webber , T. D. , Haneda , M. and Kieffer , T. J. 2009 . Incretin release from gut is acutely enhanced by sugar but not by sweeteners in vivo . Am. J. Physiol. Endocrinol. Metab , 296 : E473 – E479 .
  • Gardiner , S. J. and Begg , E. J. 2006 . Pharmacogenetics, drug-metabolizing enzymes, and clinical practice . Pharmacol. Rev , 58 : 521 – 590 .
  • Garrigues , A. , Escargueil , A. E. and Orlowski , S. 2002 . The multidrug transporter, P-glycoprotein, actively mediates cholesterol redistribution in the cell membrane . Proc. Natl. Acad. Sci. USA , 99 : 10347 – 10352 .
  • Gedeon , C. , Behravan , J. , Koren , G. and Piquette-Miller , M. 2006 . Transport of glyburide by placental ABC transporters: Implications in fetal drug exposure . Placenta , 27 : 1096 – 1102 .
  • Geick , A. , Eichelbaum , M. and Burk , O. 2001 . Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin . J. Biol. Chem , 276 : 14581 – 14587 .
  • Gemma , S. , Vittozzi , L. and Testai , E. 2003 . Metabolism of chloroform in the human liver and identification of the competent P450s . Drug Metab. Dispos , 31 : 266 – 274 .
  • Gerebtzoff , G. 2006 . In silico , Belgium. : Basel . prediction of blood-brain barrier permeation and P-glycoprotein activity. Dissertation zur Erlangung der Würde eines Doktors der Philosophie vorgelegt der Philosophisch-Naturwissenschaftlichen Fakultät der Universität Basel. Liège,
  • Ghosal , A. , Gupta , S. , Ramanathan , R. , Yuan , Y. , Lu , X. , Su , A. D. , Alvarez , N. , Zbaida , S. , Chowdhury , S. K. and Alton , K. B. 2009 . Metabolism of loratadine and further characterization of its in vitro metabolites . Drug Metab. Lett , 3 : 162 – 170 .
  • Gill , H. S. , Rutherfurd , K. J. , Cross , M. L. and Gopal , P. K. 2001 . Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019 . Am. J. Clin. Nutr , 74 : 833 – 839 .
  • Giraud , C. , Tran , A. , Rey , E. , Vincent , J. , Tréluyer , J. M. and Pons , G. 2004 . In vitro characterization of clobazam metabolism by recombinant cytochrome P450 enzymes: Importance of CYP2C19 . Drug Metab. Dispos , 32 : 1279 – 1286 .
  • Goldsmith , L. A. 2000a . Forward. . Food Chem. Toxicol , 38 ( suppl. 2 ) iii
  • Goldsmith , L. A. 2000b . Acute and subchronic toxicity of sucralose . Food Chem. Toxicol , 38 ( suppl. 2 ) : S53 – S69 .
  • Goldsmith , L. B. , Friberg , S. E. and Wahlberg , J. E. 1988 . The effect of solvent extraction on the lipids of the stratum corneum in relation to observed immediate whitening of the skin . Contact Dermatitis , 19 : 348 – 350 .
  • Golstein , P. E. , Boom , A. , van Geffel , J. , Jacobs , P. , Masereel , B. and Beauwens , R. 1999 . P-glycoprotein inhibition by glibenclamide and related compounds . Pflugers Arch , 437 : 652 – 660 .
  • Gonzalez , F. J. and Gelboin , H. V. 1994 . Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins . Drug Metab. Rev , 26 : 165 – 183 .
  • Gorski , J. C. , Hall , S. D. , Jones , D. R. , VandenBranden , M. and Wrighton , S. A. 1994 . Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily . Biochem. Pharmacol , 47 : 1643 – 1653 .
  • Gorski , J. C. , Jones , D. R. , Wrighton , S. A. and Hall , S. D. 1997 . Contribution of human CYP3A subfamily members to the 6-hydroxylation of chlorzoxazone . Xenobiotica , 27 : 243 – 256 .
  • Gottesman , M. M. and Pastan , I. 1988 . The multidrug transporter, a double-edged sword . J. Biol. Chem , 263 : 12163 – 12166 .
  • Gottesman , M. M. , Fojo , T. and Bates , S. E. 2002 . Multidrug resistance in cancer: Role of ATP-dependent transporters . Nat. Rev. Cancer , 2 : 48 – 58 .
  • Granfors , M. T. , Backman , J. T. , Laitila , J. and Neuvonen , P. J. 2004 . Tizanidine is mainly metabolized by cytochrome P450 1A2 in vitro . Br. J. Clin. Pharmacol , 57 : 349 – 353 .
  • Green , E. and Murphy , C. 2012 . Altered processing of sweet taste in the brain of diet soda drinkers . Physiol. Behav , 107 : 560 – 567 .
  • Greiner , B. , Eichelbaum , M. , Fritz , P. , Kreichgauer , H. P. , von Richter , O. , Zundler , J. and Kroemer , H. K. 1999 . The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin . J. Clin. Invest , 104 : 147 – 153 .
  • Grice , H. C. and Goldsmith , L. A. 2000 . Sucralose—An overview of the toxicity data . Food Chem. Toxicol , 38 ( suppl. 2 ) : S1 – S6 .
  • Grotz , V. L. and Munro , I. C. 2009 . An overview of the safety of sucralose . Regul. Toxicol. Pharmacol , 55 : 1 – 5 .
  • Grotz , V. L. , Henry , R. R. , McGill , J. B. , Prince , M. J. , Shamoon , H. , Trout , J. R. and Pi-Sunyer , F. X. 2003 . Lack of effect of sucralose on glucose homeostasis in subjects with type 2 diabetes . J. Am. Diet. Assoc , 103 : 1607 – 1612 .
  • Guarner , F. and Malagelada , J. R. 2003 . Gut flora in health and disease . Lancet , 361 : 512 – 519 .
  • Guengerich , F. P. 1999 . Cytochrome P-450 3A4: Regulation and role in drug metabolism . Annu. Rev. Pharmacol. Toxicol , 39 : 1 – 17 .
  • Guerrero-Bosagna , C. , Settles , M. , Lucker , B. and Skinner , M. K. 2010 . Epigenetic transgenerational actions of vinclozolin on promoter regions of the sperm epigenome . PLoS One , 5 : e13100
  • Guo , Y. , Zhang , Y. , Wang. , Y. , Chen , X. , Si , D. , Zhong , D. , Fawcett , J. P. and Zhou , H. 2005 . Role of CYP2C9 and its variants (CYP2C9*3 and CYP2C9*13) in the metabolism of lornoxicam in humans . Drug Metab. Dispos , 33 : 749 – 753 .
  • Haase , L. , Cerf-Ducastel , B. and Murphy , C. 2009 . Cortical activation in response to pure taste stimuli during the physiological states of hunger and satiety . Neuroimage , 44 : 1008 – 1021 .
  • Hakkak , R. , Ronis , M. J. and Badger , T. M. 1993 . Effects of enteral nutrition and ethanol on cytochrome P450 distribution in small intestine of male rats . Gastroenterology , 104 : 1611 – 1618 .
  • Hall , S. D. , Thummel , K. E. , Watkins , P. B. , Lown , K. S. , Benet , L. Z. , Paine , M. F. , Mayo , R. R. , Turgeon , D. K. , Bailey , D. G. , Fontana , R, J. and Wrighton , S. A. 1999 . Molecular and physical mechanisms of first-pass extraction . Drug Metab. Dispos , 27 : 161 – 166 .
  • Hamelin , B. A. , Bouayad , A. , Drolet , B. , Gravel , A. and Turgeon , J. 1998 . In vitro characterization of cytochrome P450 2D6 inhibition by classic histamine H1 receptor antagonists . Drug Metab. Dispos , 26 : 536 – 539 .
  • Handschin , C. and Meyer , U. A. 2003 . Induction of drug metabolism: The role of nuclear receptors . Pharmacol. Rev , 55 : 649 – 673 .
  • Hanioka , N. , Jinno , H. , Nishimura , T. and Ando , M. 1997 . Effect of 2,4,4’-trichloro-2’-hydroxydiphenyl ether on cytochrome P450 enzymes in the rat liver . Chemosphere , 34 : 719 – 730 .
  • Harrison , A. , Betts , A. , Fenner , K. , Beaumont , K. , Edgington , A. , Roffey , S. , Davis , J. , Comby , P. and Morgan , P. 2004 . Nonlinear oral pharmacokinetics of the α-antagonist 4-amino-5-(4-fluorophenyl)-6,7-dimethoxy-2-[4-(morpholinocarbonyl)-perhydro-1,4-diazepin-1-yl]quinoline in humans: Use of preclinical data to rationalize clinical observations . Drug Metab. Dispos , 32 : 197 – 204 .
  • Harrison , T. S. and Perry , C. M. 2004 . Aripiprazole: A review of its use in schizophrenia and schizoaffective disorder . Drugs , 64 : 1715 – 1736 .
  • Hart , A. L. , Stagg , A. J. , Frame , M. , Graffner , H. , Glise , H. , Falk , P. and Kamm , M. A. 2002 . The role of the gut flora in health and disease, and its modification as therapy . Aliment. Pharmacol. Ther , 16 : 1383 – 1393 .
  • Hatzimichael , E. , Stebbing , J. and Crook , T. 2008 . “ Methylation changes in neoplasia: Diagnostic and therapeutic implications ” . In Cancer epigenetics , Edited by: Tollefsbol , T. 399 – 414 . Boca Raton , FL : CRC Press . Ined.
  • Hawkins, D. R., Wood, S. W., Waller, A. R.Jordan, M. C.1987Enzyme induction studies of TGS and TGS-HP in the rat. Unpublished report from Huntingdon Research Centre, Huntingdon, U.K. Submitted to the World Health Organization by Tate & Lyle. Referenced in WHO (World Health Organization). 1989. Trichlorogalactosucrose. In Toxicological evaluation of certain food additives and contaminants. WHO Food Additives Series, no. 24. Cambridge University Press, 1989, no. 655.accessed February 6, 2013 http://www.inchem.org/documents/jecfa/jecmono/v024je05.htm (http://www.inchem.org/documents/jecfa/jecmono/v024je05.htm)
  • Hebert , M. F. , Fisher , R. M. , Marsh , C. L. , Dressler , D. and Bekersky , I. 1999 . Effects of rifampin on tacrolimus pharmacokinetics in healthy volunteers . J. Clin. Pharmacol , 39 : 91 – 96 .
  • Hebert , M. F. , Roberts , J. P. , Prueksaritanont , T. and Benet , L. Z. 1992 . Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction . Clin. Pharmacol. Ther , 52 : 453 – 457 .
  • Hellum , B. H. , Hu , Z. and Nilsen , O. G. 2007 . The induction of CYP1A2, CYP2D6 and CYP3A4 by six trade herbal products in cultured primary human hepatocytes . Basic Clin. Pharmacol. Toxicol , 100 : 23 – 30 .
  • Higashikawa , F. , Murakami , T. , Kaneda , T. , Kato , A. and Takano , M. 1999 . Dose-dependent intestinal and hepatic first-pass metabolism of midazolam, a cytochrome P450 3A substrate with differently modulated enzyme activity in rats . J. Pharm. Pharmacol , 51 : 67 – 72 .
  • Hijazi , Y. and Boulieu , R. 2002 . Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes . Drug Metab. Dispos , 30 : 853 – 858 .
  • Hill , M. J. 1997 . Intestinal flora and endogenous vitamin synthesis . Eur. J. Cancer Prev , 6 ( suppl. 1 ) : S43 – S45 .
  • Holtbecker , N. , Fromm , M. F. , Kroemer , H. K. , Ohnhaus , E. E. and Heidemann , H. 1996 . The nifedipine-rifampin interaction. Evidence for induction of gut wall metabolism . Drug Metab. Dispos , 24 : 1121 – 1123 .
  • Holzapfel , W. H. , Haberer , P. , Snel , J. , Schillinger , U. and Huis in't Veld , J. H . 1998 . Overview of gut flora and probiotics . J. Food Microbiol , 41 : 85 – 101 . Int
  • Hooper , L.V. , Littman , D. R. and Macpherson , A. J. 2012 . Interactions between the microbiota and the immune system . Science , 336 : 1268 – 1273 .
  • Hoskins , J. M. , Shenfield , G. M. and Gross , A. S. 1998 . Relationship between proguanil metabolic ratio and CYP2C19 genotype in a Caucasian population . Br. J. Clin. Pharmacol , 46 : 499 – 504 .
  • Hou , L. , Zhang , X. , Wang , D. and Baccarelli , A. 2012 . Environmental chemical exposures and human epigenetics . Int. J. Epidemiol , 41 : 79 – 105 .
  • Hough , L. and Khan , R. 1978 . Intensification of sweetness . Trends Biochem. Sci , 3 : 61 – 63 .
  • Hough , L. and Khan , R. 1989 . “ Enhancement of the sweetness of sucrose by conversion into chloro-deoxy derivatives ” . In Progress in sweeteners , Edited by: Grenby , T. H. 97 – 120 . London , UK : Elsevier Applied Science . Ined.
  • Hsiao , P. , Sasongko , L. , Link , J. M. , Mankoff , D. A. , Muzi , M. , Collier , A. C. and Unadkat , J. D. 2006 . Verapamil P-glycoprotein transport across the rat blood-brain barrier: Cyclosporine, a concentration inhibition analysis, and comparison with human data . J. Pharmacol. Exp. Ther , 317 : 704 – 710 .
  • Hu , S. , Chen , Z. , Franke , R. , Orwick , S. , Zhao , M. , Rudek , M. A. , Sparreboom , A. and Baker , S. D. 2009 . Interaction of the multikinase inhibitors sorafenib and sunitinib with solute carriers and ATP-binding cassette transporters . Clin. Cancer Res , 15 : 6062 – 6069 .
  • Hu , Y. and Kupfer , D. 2002 . Metabolism of the endocrine disruptor pesticide-methoxychlor by human P450s: Pathways involving a novel catechol metabolite . Drug Metab. Dispos , 30 : 1035 – 1042 .
  • Hutchinson , S. A. 1996 . The effect of pH, temperature and reactants on the thermal and non-thermal degradation of the high-intensity sweeteners: Alitame and sucralose , New Brunswick , NJ : Rutgers University . PhD dissertation
  • Hutchinson , S. A. , Ho , G. S. and Ho , C. T. 1999 . Stability and degradation of the high-intensity sweeteners: Aspartame, alitame, and sucralose . Food Rev. Int , 15 : 249 – 261 .
  • Huwyler , J. , Wright , M. B. , Gutmann , H. and Drewe , J. 2006 . Induction of cytochrome P450 3A4 and P-glycoprotein by the isoxazolyl-penicillin antibiotic flucloxacillin . Curr. Drug Metab , 7 : 119 – 126 .
  • Ibrahim , S. , Peggins , J. , Knapton , A. , Licht , T. and Aszalos , A. 2000 . Influence of antipsychotic, antiemetic, and Ca2+ channel blocker drugs on the cellular accumulation of the anticancer drug daunorubicin: P-glycoprotein modulation . J. Pharmacol. Exp. Ther , 295 : 1276 – 1283 .
  • Ieiri , I. , Kimura , M. , Irie , S. , Urae , A. , Otsubo , K. and Ishizaki , T. 2005 . Interaction magnitude, pharmacokinetics and pharmacodynamics of ticlopidine in relation to CYP2C19 genotypic status . Pharmacogenet. Genomics , 15 : 851 – 859 .
  • Ihunnah , C. A. , Jiang , M. and Xie , W. 2011 . Nuclear receptor PXR, transcriptional circuits and metabolic relevance . Biochim. Biophys. Acta , 1812 : 956 – 963 .
  • Iida , A. , Tomita , M. and Hayashi , M. 2005 . Regional difference in P-glycoprotein function in rat intestine . Drug Metab. Pharmacokinet , 20 : 100 – 106 .
  • Imai , H. , Kotegawa , T. , Tsutsumi , K. , Morimoto , T. , Eshima , N. , Nakano , S. and Ohashi , K. 2008 . The recovery time-course of CYP3A after induction by St John's wort administration . Br. J. Clin. Pharmacol , 65 : 701 – 707 .
  • Ingelman-Sundberg , M. 2005 . Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): Clinical consequences, evolutionary aspects and functional diversity . Pharmacogenomics J , 5 : 6 – 13 .
  • International Transporter Consortium , Giacomini , K. M. , Huang , S. M. , Tweedie , D. J. , Benet , L. Z. , Brouwer , K. L. , Chu , X. , Dahlin , A. , Evers , R. , Fischer , V. , Hillgren , K. M. , Hoffmaster , K. A. , Ishikawa , T. , Keppler , D. , Kim , R. B. , Lee , C. , A. , Niemi , M. , Polli , J. W. , Sugiyama , Y. , Swaan , P. W. , Ware , J. A , Wright , S. H. , Yee , S. W , Zamek-Gliszczynski , M. J and Zhang , L. 2010 . Membrane transporters in drug development . Nat. Rev. Drug Discov , 9 : 215 – 236 .
  • Isoherranen , N. , Hachad , H. , Yeung , C. K. and Levy , R. H. 2009 . Qualitative analysis of the role of metabolites in inhibitory drug-drug interactions: Literature evaluation based on the metabolism and transport drug interaction database . Chem. Res. Toxicol , 22 : 294 – 298 .
  • Iwaki , K. , Sakaeda , T. , Kakumoto , M. , Nakamura , T. , Komoto , C. , Okamura , N. , Nishiguchi , K. , Shiraki , T. , Horinouchi , M. and Okumura , K. 2006 . Haloperidol is an inhibitor but not substrate for MDR1/P-glycoprotein . J. Pharm. Pharmacol , 58 ( 1617 ) : 1622
  • Iwamoto , K. and Klaassen , C. D. 1977 . First-pass effect of morphine in rats . J. Pharmacol. Exp. Ther , 200 : 236 – 244 .
  • Jafari , F. , Garcia-Gil , L. J. , Salmanzadeh-Ahrabi , S. , Shokrzadeh , L. , Aslani , M. M. , Pourhoseingholi , M. A. , Derakhshan , F. and Zali , M. R. 2009 . Diagnosis and prevalence of enteropathogenic bacteria in children less than 5 years of age with acute diarrhea in Tehran children's hospitals . J. Infect , 58 : 21 – 27 .
  • Jang , H. J. , Kokrashvili , Z. , Theodorakis , M. J. , Carlson , O. D. , Kim , B. J. , Zhou , J. , Kim , H. H. , Xu , X. , Chan , S. L. , Juhaszova , M. , Bernier , M. , Mosinger , B. , Margolskee , R. F. and Egan , J. M. 2007 . Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1 . Proc. Natl. Acad. Sci. USA , 104 : 15069 – 15074 .
  • Jean , P. , Lopez-Garcia , P. , Dansette , P. , Mansuy , D. and Goldstein , J. L. 1996 . Oxidation of tienilic acid by human yeast-expressed cytochromes P-450 2C8, 2C9, 2C18 and 2C19. Evidence that this drug is a mechanism-based inhibitor specific for cytochrome P450 2C9 . Eur. J. Biochem , 241 : 797 – 804 .
  • Jeon , T. I. , Seo , Y. K. and Osborne , T. F. 2011 . Gut bitter taste receptor signalling induces ABCB1 through a mechanism involving CCK . Biochem. J , 438 : 33 – 37 .
  • Jia , W. , Li , H. , Zhao , L. and Nicholson , J. K. 2008 . Gut microbiota: A potential new territory for drug targeting . Nat. Rev. Drug Discov , 7 : 123 – 129 .
  • Jinno , H. , Hanioka , N. , Onodera , S. , Nishimura , T. and Ando , M. 1997 . Irgasan® DP 300 (5-chloro-2-(2,4-dichlorophenoxy)-phenol) induces cytochrome P450s and inhibits haem biosynthesis in rat hepatocytes cultured on Matrigel . Xenobiotica , 27 : 681 – 692 .
  • John , B. A. , Wood , S. G. and Hawkins , D. R. 2000a . The pharmacokinetics and metabolism of sucralose in the mouse . Food Chem. Toxicol , 38 ( suppl. 2 ) : S107 – S110 .
  • John , B. A. , Wood , S. G. and Hawkins , D. R. 2000b . The pharmacokinetics and metabolism of sucralose in the rabbit . Food Chem. Toxicol , 38 ( suppl. 2 ) : S111 – S113 .
  • Johne , A , Brockmöller , J , Bauer , S , Maurer , A , Langheinrich , M and Roots , I . 1999 . Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort . Clin. Pharmacol. Ther , 66 : 338 – 345 . Hypericum perforatum)
  • Kan , W. M. , Liu , Y. T. , Hsiao , C. L. , Shieh , C. Y. , Kuo , J. H. , Huang , J. D. and Su , S. F. 2001 . Effect of hydroxyzine on the transport of etoposide in rat small intestine . Anticancer Drugs , 12 : 267 – 273 .
  • Kansy , M. , Senner , F. and Gubernator , K. 1998 . Physicochemical high throughput screening: Parallel artificial membrane permeation assay in the description of passive absorption processes . J. Med. Chem , 41 : 1007 – 1010 .
  • Karmaus , W. , Osuch , J. R. , Eneli , I. , Mudd , L. M. , Zhang , J. , Mikucki , D. , Haan , P. and Davis , S. 2009 . Maternal levels of dichlorodiphenyl-dichloroethylene (DDE) may increase weight and body mass index in adult female offspring . Occup. Environ. Med , 66 : 143 – 149 .
  • Kato , Y. , Haraguchi , K. , Ito , Y. , Fujii , A. , Yamazaki , T. , Endo , T. , Koga , N. , Yamada , S. and Degawa , M. 2010 . Polychlorinated biphenyl-mediated decrease in serum thyroxine level in rodents . Drug Metab. Dispos , 38 : 697 – 704 .
  • Kato , Y. , Haraguchi , K. , Yamazaki , T. , Ito , Y. , Miyajima , S. , Nemoto , K. , Koga , N. , Kimura , R and Degawa , M. 2003 . Effects of polychlorinated biphenyls, kanechlor-500, on serum thyroid hormone levels in rats and mice . Toxicol. Sci , 72 : 235 – 241 .
  • Katoh , M. , Nakajima , M. , Shimada , N. , Yamazaki , H. and Yokoi , T. 2000a . Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: Prediction of in vivo drug-drug interactions . Eur. J. Clin. Pharmacol , 55 : 843 – 852 .
  • Katoh , M. , Nakajima , M. , Yamazaki , H. and Yokoi , T. 2000b . Inhibitory potencies of 1,4-dihydropyridine calcium antagonists to P-glycoprotein-mediated transport: Comparison with the effects on CYP3A4 . Pharm. Res , 17 : 1189 – 1197 .
  • Katoh , M. , Nakajima , M. , Yamazaki , H. and Yokoi , T. 2001 . Inhibitory effects of CYP3A4 substrates and their metabolites on P-glycoprotein-mediated transport . Eur. J. Pharm. Sci , 12 : 505 – 513 .
  • Kauffmann , H. M. , Pfannschmidt , S. , Zöller , H. , Benz , A. , Vorderstemann , B. , Webster , J. I. and Schrenk , D. 2002 . Influence of redox-active compounds and PXR-activators on human MRP1 and MRP2 gene expression . Toxicology , 171 : 137 – 146 .
  • Kharasch , E. D. and Thummel , K. E. 1993 . Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane . Anesthesiology , 79 : 795 – 807 .
  • Kille , J. W. , Tesh , J. M. , McAnulty , P. A. , Ross , F. W. , Willoughby , C. R. , Bailey , G. P. , Wilby , O. K. and Tesh , S. A. 2000 . Sucralose: Assessment of teratogenic potential in the rat and the rabbit . Food Chem. Toxicol , 38 ( suppl. 2 ) : S43 – S52 .
  • Kim , K. A. , Chung , J. , Jung , D. H. and Park , J. Y. 2004 . Identification of cytochrome P450 isoforms involved in the metabolism of loperamide in human liver microsomes . Eur. J. Clin. Pharmacol , 60 : 575 – 581 .
  • Kim , K. Y. and Mancano , M. A. 2003 . Fenofibrate potentiates warfarin effects . Ann. Pharmacother , 37 : 212 – 215 .
  • Kitamura , S. , Shimizu , Y. , Shiraga , Y. , Yoshida , M. , Sugihara , K. and Ohta , S. 2002 . Reductive metabolism of p,p’-DDT and o,p’-DDT by rat liver cytochrome P450 . Drug Metab. Dispos , 30 : 113 – 118 .
  • Kliewer , S. A. , Goodwin , B. and Willson , T. M. 2002 . The nuclear pregnane X receptor: A key regulator of xenobiotic metabolism . Endocr. Rev , 23 : 687 – 702 .
  • Kolars , J. C. , Awni , W. M. , Merion , R. M. and Watkins , P. B. 1991 . First-pass metabolism of cyclosporin by the gut . Lancet , 338 : 1488 – 1490 .
  • Kolars , J. C. , Lown , K. S. , Schmiedlin-Ren , P. , Ghosh , M. , Fang , C. , Wrighton , S. A. , Merion , R. M. and Watkins , P. B. 1994 . CYP3A gene expression in human gut epithelium . Pharmacogenetics , 4 : 247 – 259 .
  • Kotlyar , M. , Brauer , L. H. , Tracy , T. S. , Hatsukami , D. K. , Harris , J. , Bronars , C. A. and Adson , D. E. 2005 . Inhibition of CYP2D6 activity by bupropion . J. Clin. Psychopharmacol , 25 : 226 – 229 .
  • Kudo , S. and Odomi , M. 1998 . Involvement of human cytochrome P450 3A4 in reduced haloperidol oxidation . Eur. J. Clin. Pharmacol , 54 : 253 – 259 .
  • Kwara , A. , Lartey , M. , Sagoe , K. W. , Xexemeku , F. , Kenu , E. , Oliver-Commey , J. , Boima , V. , Sagoe , A. , Boamah , I. , Greenblatt , D. J. and Court , M. H. 2008 . Pharmacokinetics of efavirenz when co-administered with rifampin in TB/HIV co-infected patients: Pharmacogenetic effect of CYP2B6 variation . J. Clin. Pharmacol , 48 : 1032 – 1040 .
  • La Merrill , M. and Birnbaum , L. S. 2011 . Childhood obesity and environmental chemicals . Mt. Sinai J. Med , 78 : 22 – 48 .
  • Labare , M. P. and Alexander , M. 1993 . Biodegradation of sucralose, a chlorinated carbohydrate, in samples of natural environments . Environ. Toxicol. Chem , 12 : 797 – 804 .
  • Labare , M. P. and Alexander , M. 1994 . Microbial cometabolism of sucralose, a chlorinated disaccharide, in environmental samples . Appl. Microbiol. Biotechnol , 42 : 173 – 178 .
  • Lampen , A. , Zhang , Y. , Hackbarth , I. , Benet , L. Z. , Sewing , K. F. and Christians , U. 1998 . Metabolism and transport of the macrolide immunosuppressant sirolimus in the small intestine . J. Pharmacol. Exp. Ther , 285 : 1104 – 1112 .
  • Langer , P. 1998 . Polychlorinated biphenyls and the thyroid gland—Minireview . Endocr. Regul , 32 : 193 – 203 .
  • Lanning , C. L. , Fine , R. L. , Sachs , C. W. , Rao , U. S. , Corcoran , J. J. and Abou-Donia , M. B. 1996 . Chlorpyrifos oxon interacts with the mammalian multidrug resistance protein, P-glycoprotein . J. Toxicol. Environ. Health , 47 : 395 – 407 .
  • Lappin-Scott , H. M. , Holt , G. and Bull , A. T. 1987 . Microbial transformation of 1,6-dichloro-1,6-dideoxy-β,D-fructofuranosyl-4-chloro-4-deoxy-α,D-galactopyranoside (TGS) by soil populations . World J. Microbiol. Biotechnol , 3 : 95 – 102 .
  • Laurenzana , E. M. , Sorrels , S. L. and Owens , S. M. 1995 . Antipeptide antibodies targeted against specific regions of rat CYP2D1 and human CYP2D6 . Drug Metab. Dispos , 23 : 271 – 278 .
  • Le Guellec , C. , Lacarelle , B. , Catalin , J. and Durand , A. 1993 . Inhibitory effects of anticancer drugs on dextromethorphan-O-demethylase activity in human liver microsomes . Cancer Chemother. Pharmacol , 32 : 491 – 495 .
  • 2011 . “ Leatherhead Food Research. ” . In The global food additives market , September. Leatherhead, Surrey, UK : Leatherhead . 5thed.
  • Lee , D. H. , Lee , I. K. , Song , K. , Steffes , M. , Toscano , W. , Baker , B. A. and Jacobs , D. R. 2006 . A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: Results from the National Health and Examination Survey 1999–2002 . Diabetes Care , 29 : 1638 – 1644 . Jr
  • Lee , S. M. , Donaldson , G. P. , Mikulski , Z. , Boyajian , S. , Ley , K. and Mazmanian , S. K. 2013 . “ Bacterial colonization factors control specificity and stability of the gut microbiota ” . In Nature doi:10.1038/nature12447
  • Leffingwell , J. 2011 . Flavor properties of FEMA GRAS LIST 25 flavor chemicals . Perfum. Flavorist , 36 : 24 – 31 . June
  • Lemke , T. L. , Williams , D. A. , Roche , V. F. and Zito , S. W. 2008 . Foye's principles of medicinal chemistry , 267 – 268 . Baltimore , MD : Lippincott Williams and Wilkins .
  • Ley , R. E. , Turnbaugh , P. J. , Klein , S. and Gordon , J. I. 2006 . Microbial ecology: Human gut microbes associated with obesity . Nature , 444 : 1022 – 1023 .
  • Li , X.-Q. , Björkman , A. , Andersson , T. B. , Ridderström , M. and Masimirembwa , C. M. 2002 . Amodiaquine clearance and its metabolism to N-desethylamodiaquine is mediated by CYP2C8: A new high affinity and turnover enzyme-specific probe substrate . J. Pharmacol. Exp. Ther , 300 : 399 – 407 .
  • Li , X. , Du , Z. , Huang , X. , Yuan , W. and Ying , H. 2010 . Solubility of sucralose in different solvents from (283.15 to 333.15) K . J. Chem. Eng. Data , 55 : 2600 – 2602 .
  • Lilja , J. J. , Niemi , M. , Fredrikson , H. and Neuvonen , P. J. 2007 . Effects of clarithromycin and grapefruit juice on the pharmacokinetics of glibenclamide . Br. J. Clin. Pharmacol , 63 : 732 – 740 .
  • Lima , S. A. C. , Tavares , J. , Gameiro , P. , de Castro , B. and Cordeiro-da-Silva , A. 2008 . Flurazepam inhibits the P-glycoprotein transport function: An insight to revert multidrug-resistance phenotype . Eur. J. Pharmacol , 581 : 30 – 36 .
  • Lin , J. H. and Yamazaki , M. 2003 . Role of P-glycoprotein in pharmacokinetics: Clinical implications . Clin. Pharmacokinet , 42 : 59 – 98 .
  • Lin , J. H. , Liu , L. Y. , Yang , M. H. and Lee , M. H. 2004 . Ethyl acetate/ethyl alcohol mixtures as an alternative to Folch reagent for extracting animal lipids . J. Agric. Food Chem , 52 : 4984 – 4986 .
  • Lipscomb , J. C. , Garrett , C. M. and Snawder , J. E. 1997 . Cytochrome P450-dependent metabolism of trichloroethylene: Interindividual differences in humans . Toxicol. Appl. Pharmacol , 142 : 311 – 318 .
  • Lown , K. S. , Kolars , J. C. , Thummel , K. E. , Barnett , J. L. , Kunze , K. L. , Wrighton , S. A. and Watkins , P. B. 1994 . Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test . Drug Metab. Dispos , 22 : 947 – 955 .
  • Lutsey , P. L. , Steffen , L. M. and Stevens , J. 2008 . Dietary intake and the development of the metabolic syndrome: The Atherosclerosis Risk in Communities study . Circulation , 117 : 754 – 761 .
  • Ma , J. , Bellon , M. , Wishart , J. M. , Young , R. , Blackshaw , L. A. , Jones , K. L. , Horowitz , M. and Rayner , C. K. 2009 . Effect of the artificial sweetener, sucralose, on gastric emptying and incretin hormone release in healthy subjects . Am. J. Physiol. Gastrointest. Liver Physiol , 296 : G735 – G739 .
  • Ma , J. , Chang , J. , Checklin , H. L. , Young , R. L. , Jones , K. L. , Horowitz , M. and Rayner , C. K. 2010 . Effect of the artificial sweetener, sucralose, on small intestinal glucose absorption in healthy human subjects . Br. J. Nutr , 104 : 803 – 806 .
  • Mace , O. J. , Affleck , J. , Patel , N. and Kellett , G. L. 2007 . Sweet taste receptors in rat small intestine stimulate glucose absorption through apical GLUT2 . J. Physiol , 582 : 379 – 392 .
  • Mace , O. J. , Lister , N. , Morgan , E. , Shepherd , E. , Affleck , J. , Helliwell , P. , Bronk , J. R. , Kellett , G. L. , Meredith , D. , Boyd , R. , Pieri , M. , Bailey , P. D. , Pettcrew , R. and Foley , D. 2009 . An energy supply network of nutrient absorption coordinated by calcium and T1R taste receptors in rat small intestine . J. Physiol , 587 : 195 – 210 .
  • Mahar Doan , K. M. , Humphreys , J. E. , Webster , L. O. , Wring , S. A. , Shampine , L. J. , Serabjit-Singh , C. J. , Adkison , K. K. and Polli , J. W. 2002 . Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs . J. Pharmacol. Exp. Ther , 303 : 1029 – 1037 .
  • Maitra , R. , Halpin , P. A. , Karlson , K. H. , Page , R. L. , Paik , D. Y. , Leavitt , M. O. , Moyer , B. D. , Stanton , B. A. and Hamilton , J. W. 2001 . Differential effects of mitomycin C and doxorubicin on P-glycoprotein expression . Biochem J , 355 : 617 – 624 .
  • Mann , A. , Miksys , S. , Lee , A. , Mash , D. C. and Tyndale , R. F. 2008 . Induction of the drug metabolizing enzyme CYP2D in monkey brain by chronic nicotine treatment . Neuropharmacology , 55 : 1147 – 1155 .
  • Mann , S. W. , Yuschak , M. M. , Amyes , S. J. G. , Aughton , P. and Finn , J. P. 2000a . A carcinogenicity study of sucralose in the CD-1 mouse . Food Chem. Toxicol , 38 ( suppl. 2 ) : S91 – S98 .
  • Mann , S. W. , Yuschak , M. M. , Amyes , S. J. G. , Aughton , P. and Finn , J. P. 2000b . A combined chronic toxicity/carcinogenicity study of sucralose in Sprague-Dawley rats . Food Chem. Toxicol , 38 ( suppl. 2 ) : S71 – S89 .
  • Mao-Qiang , M. , Feingold , K. R. , Wang , F. , Thornfeldt , C. R. and Elias , P. M. 1996 . A natural lipid mixture improves barrier function and hydration in human and murine skin . J. Soc. Cosmet. Chem , 47 : 157 – 166 .
  • Marchetti , S. , Mazzanti , R. , Beijnen , J. H. and Schellens , J. H. 2007 . Concise review: Clinical relevance of drug drug and herb drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein) . Oncologist , 12 : 927 – 941 .
  • Margolskee , R. F. , Dyer , J. , Kokrashvili , Z. , Salmon , K. S. H. , Ilegems , E. , Daly , K. , Maillet , E. L. , Ninomiya , Y. , Mosinger , B. and Shirazi-Beechey , S. P. 2007 . T1R3 and gustducin in gut sense sugars to regulate expression of Na+-glucose cotransporter 1 . Proc. Natl. Acad. Sci. USA , 104 : 15075 – 15080 .
  • Masuda , S. , Uemoto , S. , Hashida , T. , Inomata , Y. , Tanaka , K. and Inui , K. 2000 . Effect of intestinal P-glycoprotein on daily tacrolimus trough level in a living-donor small bowel recipient . Clin. Pharmacol. Ther , 68 : 98 – 103 .
  • Matheny , C. J. , Ali , R. Y. , Yang , X. and Pollack , G. M. 2004 . Effect of prototypical inducing agents on P-glycoprotein and CYP3A expression in mouse tissues . Drug Metab. Dispos , 32 : 1008 – 1014 .
  • Matheny , C. J. , Lamb , M. W. , Brouwer , K. R. and Pollack , G. M. 2001 . Pharmacokinetic and pharmacodynamic implications of P-glycoprotein modulation . Pharmacotherapy , 21 : 778 – 779 .
  • Matsubara , T. , Kim , H. J. , Miyata , M. , Shimada , M. , Nagata , K. and Yamazoe , Y. 2004 . Isolation and characterization of a new major intestinal CYP3A form, CYP3A62, in the rat . J. Pharmacol. Exp. Ther , 309 : 1282 – 1290 .
  • May-Manke , A. , Kroemer , H. , Hempel , G. , Bohnenstengel , F. , Hohenlöchter , B. , Blaschke , G. and Boos , J. 1999 . Investigation of the major human hepatic cytochrome P450 involved in 4-hydroxylation and N-dechloroethylation of trofosfamide . Cancer Chemother. Pharmacol , 44 : 327 – 334 .
  • McKay , J. A. and Mathers , J. C. 2011 . Diet induced epigenetic changes and their implications for health . Acta Physiol. (Oxford) , 202 : 103 – 118 .
  • Mechetner , E. , Kyshtoobayeva , A. , Zonis , S. , Kim , H. , Stroup , R. , Garcia , R. , Parker , R. J. and Fruehauf , J. P. 1998 . Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin . Clin. Cancer Res , 4 : 389 – 398 .
  • Meijerman , I. , Beijnen , J. H. and Schellens , J. H. 2008 . Combined action and regulation of phase II enzymes and multidrug resistance proteins in multidrug resistance in cancer . Cancer Treat. Rev , 34 : 505 – 520 .
  • Meinl , W. , Sczesny , S. , Brigelius-Flohé , R. , Blaut , M. and Glatt , H. 2009 . Impact of gut microbiota on intestinal and hepatic levels of phase 2 xenobiotic-metabolizing enzymes in the rat . Drug Metab. Dispos , 37 : 1179 – 1186 .
  • Mezitis , N. H. , Maggio , C. A. , Koch , P. , Quddoos , A. , Allison , D. B. and Pi-Sunyer , F. X. 1996 . Glycemic effect of a single high oral dose of the novel sweetener sucralose in patients with diabetes . Diabetes Care , 19 : 1004 – 1005 .
  • Middleton , J. H. and Salierno , J. D. 2013 . Antibiotic resistance in triclosan tolerant fecal coliforms isolated from surface waters near wastewater treatment plant outflows (Morris County, NJ, USA) . Ecotoxicol. Environ. Safety , 88 : 79 – 88 .
  • Miksys , S. , Rao , Y. , Hoffmann , E. , Mash , D. C. and Tyndale , R. F. 2002 . Regional and cellular expression of CYP2D6 in human brain: Higher levels in alcoholics . J. Neurochem , 82 : 1376 – 1387 .
  • Miller , D. B. and Spence , J. D. 1998 . Clinical pharmacokinetics of fibric acid derivatives (fibrates) . Clin. Pharmacokinet , 34 : 155 – 162 .
  • Miller , G. A. 1991 . “ Sucralose ” . In Alternative sweeteners , Edited by: O'Brien Nabors , L. and Gelardi , R. C. 173 – 195 . New York , NY : Marcel Dekker . In2ndeded
  • Mitschke , D. , Reichel , A. , Fricker , G. and Moenning , U. 2008 . Characterization of cytochrome P450 protein expression along the entire length of the intestine of male and female rats . Drug Metab Dispos , 36 : 1039 – 1045 .
  • Miura , M. , Otani , K. and Ohkubo , T. 2005 . Identification of human cytochrome P450 enzymes involved in the formation of 4-hydroxyestazolam from estazolam . Xenobiotica , 35 : 455 – 465 .
  • Miyama , T. , Takanaga , H. , Matsuo , H. , Yamano , K. , Yamamoto , K. , Iga , T. , Naito , M. , Tsuruo , T. , Ishizuka , H. , Kawahara , Y. and Sawada , Y. 1998 . P-glycoprotein-mediated transport of itraconazole across the blood–brain barrier . Antimicrob. Agents Chemother , 42 : 1738 – 1744 .
  • Molinary , S. V. and Quinlan , M. E. 2006 . “ Sucralose ” . In Sweeteners and sugar alternatives in food technology , Edited by: Mitchell , H. 130 – 148 . Oxford , UK : Blackwell . Ined.
  • Mrozikiewicz , P. M. , Bogacz , A. , Karasiewicz , M. , Mikolajczak , P. L. , Ozarowski , M. , Seremak-Mrozikiewicz , A. , Czerny , B. , Bobkiewicz-Kozlowska , T. and Grzeskowiak , E. 2010 . The effect of standardized Echinacea purpurea extract on rat cytochrome P450 expression level . Phytomedicine , 17 : 830 – 833 .
  • Najib , J. 2006 . Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia . Clin. Ther , 28 : 491 – 516 .
  • Nakagawa , Y. , Nagasawa , M. , Yamada , S. , Hara , A. , Mogami , H. , Nikolaev , V. O. , Lohse , M. J. , Shigemura , N. , Ninomiya , Y. and Kojima , I. 2009 . Sweet taste receptor expressed in pancreatic ß-cells activates the calcium and cyclic AMP signaling systems and stimulates insulin secretion . PLoS One , 4 : e5106
  • Nakajima , M. , Nakamura , S. , Tokudome , S. , Shimada , N. , Yamazaki , H. and Yokoi , T. 1999b . Azelastine N-demethylation by cytochrome P-450 (CYP)3A4, CYP2D6, and CYP1A2 in human liver microsomes: Evaluation of approach to predict the contribution of multiple CYPs . Drug Metab. Dispos , 27 : 1381 – 1391 .
  • Nakajima , M. , Ohyama , K. , Nakamura , S. , Shimada , N. , Yamazaki , H. and Yokoi , T. 1999a . Inhibitory effects of azelastine and its metabolites on drug oxidation catalyzed by human cytochrome P-450 enzymes . Drug Metab. Dispos , 27 : 792 – 797 .
  • Need , A. C. , Motulsky , A. G. and Goldstein , D. B. 2005 . Priorities and standards in pharmacogenetic research . Nat. Genet , 37 : 671 – 681 .
  • Nicholson , J. K. , Holmes , E. and Wilson , I. D. 2005 . Gut microorganisms, mammalian metabolism and personalized health care . Nat. Rev. Microbiol , 3 : 431 – 438 .
  • Nishiya , Y. , Hagihara , K. , Ito , T. , Tajima , M. , Miura , S. , Kurihara , A. , Farid , N. A. and Ikeda , T. 2009 . Mechanism-based inhibition of human cytochrome P450 2B6 by ticlopidine, clopidogrel, and the thiolactone metabolite of prasugrel . Drug Metab. Dispos , 37 : 589 – 593 .
  • Niwa , T. , Shiraga , T. , Ishii , I. , Kagayama , A. and Takagi , A. 2005 . Contribution of human hepatic cytochrome p450 isoforms to the metabolism of psychotropic drugs . Biol. Pharm. Bull , 28 : 1711 – 1716 .
  • Nowack , R. , Andrassy , J. , Fischereder , M. and Unger , M. 2009 . Effects of dietary factors on drug transport and metabolism: The impact on dosage guidelines in transplant patients . Clin. Pharmacol. Ther , 85 : 439 – 443 .
  • Nyakutira , C. , Röshammar , D. , Chigutsa , E. , Chonzi , P. , Ashton , M. , Nhachi , C. and Masimirembwa , C. 2008 . High prevalence of the CYP2B6 516G-->T(*6) variant and effect on the population pharmacokinetics of efavirenz in HIV/AIDS outpatients in Zimbabwe . Eur. J. Clin. Pharmacol , 64 : 357 – 365 .
  • Obach , R. S. , Cox , L. M. and Tremaine , L. M. 2005 . Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study . Drug Metab. Dispos , 33 : 262 – 270 .
  • O'Brien , P. J. , Siraki , A. G. and Shangari , N. 2005 . Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health . Crit. Rev. Toxicol , 35 : 609 – 662 .
  • O'Flaherty , S. and Klaenhammer , T. R. 2010 . The role and potential of probiotic bacteria in the gut, and the communication between gut microflora and gut/host . Int. Dairy J , 20 : 262 – 268 .
  • Olesen , O. V. and Linnet , K. 2000 . Identification of the human cytochrome P450 isoforms mediating in vitro N-dealkylation of perphenazine . Br. J. Clin. Pharmacol , 50 : 563 – 571 .
  • Olesen , O. V. and Linnet , K. 2001 . Contributions of five human cytochrome P450 isoforms to the N-demethylation of clozapine in vitro at low and high concentrations . J. Clin. Pharmacol , 41 : 823 – 832 .
  • Ong , C. E. , Coulter , S. , Birkett , D. J. , Bhasker , C. R. and Miners , J. O. 2000 . The xenobiotic inhibitor profile of cytochrome P4502C8 . Br. J. Clin. Pharmacol , 50 : 573 – 580 .
  • Ono , S. , Hatanaka , T. , Miyazawa , S. , Tsutsui , M. , Aoyama , T. , Gonzalez , F. J. and Satoh , T. 1996 . Human liver microsomal diazepam metabolism using cDNA-expressed cytochrome P450s: Role of CYP2B6, 2C19 and the 3A subfamily . Xenobiotica , 26 : 1155 – 1166 .
  • O'Toole , P. W. and Claesson , M. J. 2010 . Gut microbiota: Changes throughout the lifespan from infancy to elderly . Int. Dairy J , 20 : 281 – 291 .
  • Paine , M. F. 2009 . “ Sites of extra hepatic metabolism, Part II: Gut ” . In Handbook of drug metabolism , Edited by: Pearson , P. G. and Wienkers , L. C. 273 – 298 . New York , NY : Informa Healthcare USA . In2nded.ed
  • Paine , M. F. and Thummel , K. E. 2003 . “ Role of intestinal cytochromes P450 in drug disposition ” . In Drug metabolizing enzymes: cytochrome P450 and other enzymes in drug discovery and development , Edited by: Lee , J. S. , Obach , R. S. and Fisher , M. B. 421 – 452 . New York , NY : Marcel Dekker . Ined
  • Paine , M. F. , Hart , H. L. , Ludington , S. S. , Haining , R. L. , Rettie , A. E. and Zeldin , D. C. 2006 . The human intestinal cytochrome P450 "pie" . Drug Metab. Dispos , 34 : 880 – 886 .
  • Paine , M. F. , Shen , D. D. , Kunze , K. L. , Perkins , J. D. , Marsh , C. L. , McVicar , J. P. , Barr , D. M. , Gillies , B. S. and Thummel , K. E. 1996 . First-pass metabolism of midazolam by the human intestine . Clin. Pharmacol. Ther , 60 : 14 – 24 .
  • Pan , Y. Z. , Gao , W. and Yu , A. M. 2009 . MicroRNAs regulate CYP3A4 expression via direct and indirect targeting . Drug Metab. Dispos , 37 : 2112 – 2117 .
  • Pang , S. , Cao , J. Q. , Katz , B. H. , Hayes , C. L. , Sutter , T. R. and Spink , D. C. 1999 . Inductive and inhibitory effects of non-ortho-substituted polychlorinated biphenyls on estrogen metabolism and human cytochromes P450 1A1 and 1B1 . Biochem. Pharmacol , 58 : 29 – 38 .
  • Park , J. Y. , Kim , K. A. and Kim , S. L. 2003 . Chloramphenicol is a potent inhibitor of cytochrome P450 isoforms CYP2C19 and CYP3A4 in human liver microsomes . Antimicrob. Agents Chemother , 47 : 3464 – 3469 .
  • Park , J. Y. , Kim , K. A. , Kang , M. H. , Kim , S. L. and Shin , J. G. 2004 . Effect of rifampin on the pharmacokinetics of rosiglitazone in healthy subjects . Clin. Pharmacol. Ther , 75 : 157 – 162 .
  • Pelkonen , O. , Turpeinen , M. , Hakkola , J. , Honkakoski , P. , Hukkanen , J. and Raunio , H. 2008 . Inhibition and induction of human cytochrome P450 enzymes: Current status . Arch. Toxicol , 82 : 667 – 715 .
  • Pepino , M. Y. , Tiemann , C. D. , Patterson , B. W. , Wice , B. M. and Klein , S. 2013 . Sucralose affects glycemic and hormonal responses to an oral glucose load . Diabetes Care , 36 : 2530 – 2535 .
  • Pfuhler , S. , Fellows , M. , van Benthem , J. , Corvi , R. , Curren , R. , Dearfield , K. , Fowler , P. , Frötschl , R. , Elhajouji , A. , Le Hégarat , L. , Kasamatsu , T. , Kojima , H. , Ouédraogo , G. , Scott , A. and Speit , G. 2011 . In vitro genotoxicity test approaches with better predictivity: Summary of an IWGT workshop . Mutat. Res , 723 : 101 – 107 .
  • Pharmacogenomics Knowledge Base. 2013accessed February 6, 2013 http://www.pharmgkb.org (http://www.pharmgkb.org)
  • Pirmohamed , M. , Williams , D. , Madden , S. , Templeton , E. and Park , B. K. 1995 . Metabolism and bioactivation of clozapine by human liver in vitro . J. Pharmacol. Exp. Ther , 272 : 984 – 990 .
  • Piscitelli , S. C. , Burstein , A. H. , Chaitt , D. , Alfaro , R. M. and Falloon , J. 2000 . Indinavir concentrations and St John's wort . Lancet , 355 : 547 – 548 .
  • Polli , J. W. , Wring , S. A. , Humphreys , J. E. , Huang , L. , Morgan , J. B. , Webster , L. O. and Serabjit-Singh , C. S. 2001 . Rational use of in vitro P-glycoprotein assays in drug discovery . J. Pharmacol. Exp. Ther , 299 : 620 – 628 .
  • Porta , M. 2006 . Persistent organic pollutants and the burden of diabetes . Lancet , 368 : 558 – 559 .
  • Prakash , C. , Kamel , A. , Cui , D. , Whalen , R. D. , Miceli , J. J. and Tweedie , D. 2000 . Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions . Br. J. Clin. Pharmacol , 49 ( suppl. 1 ) : 35S – 42S .
  • Prashant , G. M. , Patil , R. B. , Nagaraj , T. and Patel , V. B. 2012 . The antimicrobial activity of the three commercially available intense sweeteners against common periodontal pathogens: An in vitro study . J. Contemp. Dent. Pract , 13 : 749 – 752 .
  • Preissner , S. , Kroll , K. , Dunkel , M. , Senger , C. , Goldsobel , G. , Kuzman , D. , Guenther , S. , Winnenburg , R. , Schroeder , M. and Preissner , R. 2010 . SuperCYP: A comprehensive database on cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions . Nucleic Acids Res. , 38 : D237 – D243 . database issue
  • Prior , T. I. , Chue , P. S. , Tibbo , P. and Baker , G. B. 1999 . Drug metabolism and atypical antipsychotics . Eur. Neuropsychopharmacol , 9 : 301 – 309 .
  • Projean , D. , Baune , B. , Farinotti , R. , Flinois , J. P. , Beaune , P. , Taburet , A. M. and Ducharme , J. 2003 . In vitro metabolism of chloroquine: Identification of CYP2C8, CYP3A4, and CYP2D6 as the main isoforms catalyzing N-desethylchloroquine formation . Drug Metab. Dispos , 31 : 748 – 754 .
  • Qin , X. 2011 . What caused the recent worldwide increase of inflammatory bowel disease: Should sucralose be added as a suspect? . Inflamm. Bowel Dis , 17 : E139
  • Qin , X. 2012 . Etiology of inflammatory bowel disease: A unified hypothesis . World J. Gastroenterol , 18 : 1708 – 1722 .
  • Rahn , A. and Yaylayan , V. A. 2010 . Thermal degradation of sucralose and its potential in generating chloropropanols in the presence of glycerol . Food Chem , 118 : 56 – 61 .
  • Rajilić-Stojanović , M. , Heilig , H. G. , Tims , S. , Zoetendal , E. G. and de Vos , W. M. 2012 . “ Long-term monitoring of the human intestinal microbiota composition ” . In Environ. Microbiol doi:10.1111/1462-2920.12023.
  • Ramesh , B. , Adkar , S. S. , Prabhudesai , A. V. and Viswanathan , C. V. 1979 . Selective extraction of phospholipids from egg yolk . J. Am. Oil Chem. Soc , 56 : 585 – 587 .
  • Rao , U. S. , Fine , R. L. and Scarborough , G. A. 1994 . Antiestrogens and steroid hormones: substrates of the human P-glycoprotein . Biochem. Pharmacol , 48 : 287 – 292 .
  • Ren , X. , Zhou , L. , Terwilliger , R. , Newton , S. S. and de Araujo , I. E. 2009 . Sweet taste signaling functions as a hypothalamic glucose sensor . Front. Integr. Neurosci , 3 : 12
  • Riegelman , S. and Rowland , M. 1973 . Effect of route of administration on drug disposition . J. Pharmacokinet. Biopharm , 1 : 419 – 434 .
  • Roberts , A. , Renwick , A. G. , Sims , J. and Snodin , D. J. 2000 . Sucralose metabolism and pharmacokinetics in man . Food Chem. Toxicol , 38 ( suppl. 2 ) : S31 – S41 .
  • Robison , T. W. and Jacobs , A. 2009 . Metabolites in safety testing . Bioanalysis , 1 : 1193 – 1200 .
  • Ross , R. P. , Mills , S. , Hill , C. , Fitzgerald , G. F. and Stanton , C. 2010 . Specific metabolite production by gut microbiota as a basis for probiotic function . Int. Dairy J , 20 : 269 – 276 .
  • Rotzinger , S. , Fang , J. and Baker , G. B. 1998 . Trazodone is metabolized to m-chlorophenylpiperazine by CYP3A4 from human sources . Drug Metab. Dispos , 26 : 572 – 575 .
  • Rowland , M. and Tozer , T. N. 2011 . “ Nonlinearities ” . In Clinical pharmacokinetics and pharmacodynamics. Concepts and applications , 445 – 482 . Baltimore , MD : Lippincott Williams & Wilkins . In4thed
  • Rudenga , K. J. and Small , D. M. 2012 . Amygdala response to sucrose consumption is inversely related to artificial sweetener use . Appetite , 58 : 504 – 507 .
  • Ruschitzka , F. , Meier , P. J. , Turina , M. , Lüscher , T. F. and Noll , G. 2000 . Acute heart transplant rejection due to Saint John's wort . Lancet , 355 : 548 – 549 .
  • Russell , A. D. 1998 . Bacterial resistance to disinfectants: Present knowledge and future problems . J. Hosp. Infect , 43 ( suppl ) : S57 – S68 .
  • Russell , A. D. 2004 . Bacterial adaptation and resistance to antiseptics, disinfectants and preservatives is not a new phenomenon . J. Hosp. Infect , 57 : 97 – 104 .
  • Saitoh , R. , Miyayama , T. , Mitsui , T. , Akiba , Y. , Higashida , A. , Takata , S. , Kawanishi , T. , Aso , Y. , Itoh , Z. and Omura , S. 2007 . Nonlinear intestinal pharmacokinetics of mitemcinal, the first acid-resistant non-peptide motilin receptor agonist, in rats . Xenobiotica , 37 : 1421 – 1432 .
  • Sasaki , Y. F. , Kawaguchi , S. , Kamaya , A. , Ohshita , M. , Kabasawa , K. , Iwama , K. , Taniguchi , K. and Tsuda , S. 2002 . The comet assay with 8 mouse organs: Results with 39 currently used food additives . Mutat. Res , 519 : 103 – 119 .
  • Schiffman , S. S. 2012 . Rationale for further medical and health research on high-potency sweeteners . Chem. Senses , 37 : 671 – 679 .
  • Schiffman , S. S. and Abou-Donia , M. B. 2012 . Sucralose revisited: Rebuttal of two papers about Splenda safety . Regul. Toxicol. Pharmacol , 63 : 505 – 508 .
  • Schiffman , S. S. and Gatlin , C. A. 1993 . Sweeteners: State of knowledge review . Neurosci. Biobehav Rev , 17 : 313 – 345 .
  • Schiffman , S. S. , Booth , B. J. , Losee , M. L. , Pecore , S. D. and Warwick , Z. S. 1995 . Bitterness of sweeteners as a function of concentration . Brain Res. Bull , 36 : 505 – 513 .
  • Schiffman , S. S. , Cahn , H. and Lindley , M. G. 1981 . Multiple receptor sites mediate sweetness: Evidence from cross adaptation . Pharmacol. Biochem. Behav , 15 : 377 – 388 .
  • Schiffman , S. S. , Hornack , K. and Reilly , D. 1979 . Increased taste thresholds of amino acids with age . Am. J. Clin. Nutr , 32 : 1622 – 1627 .
  • Schiffman , S. S. , Reilly , D. A. and Clark , T. B. 1979 . Qualitative differences among sweeteners . Physiol. Behav , 23 : 1 – 9 . 3rd
  • Schiffman , S. S. , Sattely-Miller , E. A. and and Bishay , I. E. 2008 . “ Sensory properties of neotame: Comparison with other sweeteners ” . In Sweetness and sweeteners: Biology, chemistry and psychophysics , Edited by: Weerasinghe , D. K. and DuBois , G. E. 511 – 529 . New York , NY : Oxford University Press . InedACS Symposium Series
  • Schinkel , A. H. , Wagenaar , E. , Mol , C. A. and van Deemter , L. 1996 . P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs . J. Clin. Invest , 97 : 2517 – 2524 .
  • Schuetz , E. G. , Beck , W. T. and Schuetz , J. D. 1996 . Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells . Mol. Pharmacol , 49 : 311 – 318 .
  • Schwab , D. , Fischer , H. , Tabatabaei , A. , Poli , S. and Huwyler , J. 2003 . Comparison of in vitro P-glycoprotein screening assays: Recommendations for their use in drug discovery . J. Med. Chem , 46 : 1716 – 1725 .
  • Scientific Committee on Food. 2000. Opinion of the Scientific Committee on Food on Sucralose (adopted by the SCF on 7 September 2000). SCF/CS/ADDS/EDUL/190 Final 12/9/2000. European Commission. Health & Consumer Protection Directorate-Generalaccessed February 6, 2013 ec.europa.eu/food/fs/sc/scf/out68_en.pdf (http://ec.europa.eu/food/fs/sc/scf/out68_en.pdf)
  • Scientific Committee on Food. 2001. Opinion of the Scientific Committee on Food on 3-monochloro-propane-1,2-diol (3-MCPD). European Commission, Health and Consumer Protection Directorate-Generalaccessed February 6, 2013 http://ec.europa.eu/food/fs/sc/scf/out91_en.pdf (http://ec.europa.eu/food/fs/sc/scf/out91_en.pdf)
  • Screnci , D. , McKeage , M. J. , Galettis , P. , Hambley , T. W. , Palmer , B. D. and Baguley , B. C. 2000 . Relationships between hydrophobicity, reactivity, accumulation and peripheral nerve toxicity of a series of platinum drugs . Br. J. Cancer , 82 : 966 – 972 .
  • Sérée , E. , Villard , P. H. , Pascussi , J. M. , Pineau , T. , Maurel , P. , Nguyen , Q. B. , Fallone , F. , Martin , P. M. , Champion , S. , Lacarelle , B. , Savouret , J. F. and Barra , Y. 2004 . Evidence for a new human CYP1A1 regulation pathway involving PPAR-alpha and 2 PPRE sites . Gastroenterology , 127 : 1436 – 1445 .
  • Servant , G. , Tachdjian , C. , Li , X. and Karanewsky , DS. 2011 . The sweet taste of true synergy: positive allosteric modulation of the human sweet taste receptor . Trends Pharmacol. Sci , 32 : 631 – 636 .
  • Servant , G. , Tachdjian , C. , Tang , X. Q. , Werner , S. , Zhang , F. , Li , X. , Kamdar , P. , Petrovic , G. , Ditschun , T. , Java , A. , Brust , P. , Brune , N. , DuBois , G. E. , Zoller , M. and Karanewsky , D. S. 2010 . Positive allosteric modulators of the human sweet taste receptor enhance sweet taste . Proc. Natl. Acad. Sci. USA , 107 : 4746 – 4751 .
  • Shearer , M. J. 1995 . Vitamin K . Lancet , 345 : 229 – 234 .
  • Sherman , P. M. , Ossa , J. C. and Johnson-Henry , K. 2009 . Unraveling mechanisms of action of probiotics . Nutr. Clin. Pract , 24 : 10 – 14 .
  • Shimada , T. , Terada , A. , Yokogawa , K. , Kaneko , H. , Nomura , M. , Kaji , K. , Kaneko , S. , Kobayashi , K. and Miyamoto , K. 2002 . Lowered blood concentration of tacrolimus and its recovery with changes in expression of CYP3A and P-glycoprotein after high-dose steroid therapy . Transplantation , 74 : 1419 – 1424 .
  • Shimomura , M. , Masuda , S. , Saito , H. , Sakamoto , S. , Uemoto , S. , Tanaka , K. and Inui , K. 2002 . Roles of the jejunum and ileum in the first-pass effect as absorptive barriers for orally administered tacrolimus . J. Surg. Res , 103 : 215 – 222 .
  • Shiraga , T. , Kaneko , H. , Iwasaki , K. , Tozuka , Z. , Suzuki , A. and Hata , T. 1999 . Identification of cytochrome P450 enzymes involved in the metabolism of zotepine, an antipsychotic drug, in human liver microsomes . Xenobiotica , 29 : 217 – 229 .
  • Shon , J. H. , Yoon , Y. R. , Kim , M. J. , Kim , K. A. , Lim , Y. C. , Liu , K. H. , Shin , D. H. , Lee , C. H. , Cha , I. J. and Shin , J. G. 2005 . Chlorpropamide 2-hydroxylation is catalysed by CYP2C9 and CYP2C19 in vitro: Chlorpropamide disposition is influenced by CYP2C9, but not by CYP2C19 genetic polymorphism . Br. J. Clin. Pharmacol , 59 : 552 – 563 .
  • Shugarts , S. and Benet , L. Z. 2009 . The role of transporters in the pharmacokinetics of orally administered drugs . Pharm. Res , 26 : 2039 – 2054 .
  • Simooya , O. O. , Sijumbil , G. , Lennard , M. S. and Tucker , G. T. 1998 . Halofantrine and chloroquine inhibit CYP2D6 activity in healthy Zambians . Br. J. Clin. Pharmacol , 45 : 315 – 317 .
  • Sims , J. , Roberts , A. , Daniel , J. W. and Renwick , A. G. 2000 . The metabolic fate of sucralose in rats . Food Chem. Toxicol , 38 ( suppl. 2 ) : S115 – S121 .
  • Smith , R. L. , Cohen , S. M. , Doull , J. , Feron , V. J. , Goodman , J. I. , Marnett , L. J. , Munro , I. C. , Portoghese , P. S. , Waddell , W. J. , Wagner , B. M. and Adams , T. B. Expert Panel of the Flavor and Extract Manufacturers Association. 2005. Criteria for the safety evaluation of flavoring substances. The Expert Panel of the Flavor and Extract Manufacturers Association . Food Chem. Toxicol , 43 1141 – 1177 .
  • Smith , R. L. , Waddell , W. J. , Cohen , S. M. , Fukushima , S. , Gooderham , N. J. , Hecht , S. S. , Marnett , L. J. , Portoghese , P. S. , Rietjens , I. M. C. M. , Adams , T. B. , Lucas Gavin , C. , McGowen , M. M. and Taylor , S. V. 2011 . GRAS Flavoring Substances 25 . Food Technol , 65 : 44 – 75 .
  • Soldner , A. , Benet , L. Z. , Mutschler , E. and Christians , U. 2000 . Active transport of the angiotensin-II antagonist losartan and its main metabolite EXP 3174 across MDCK-MDR1 and Caco-2 cell monolayers . Br. J. Pharmacol , 129 : 1235 – 1243 .
  • Sparreboom , A. , van Asperen , J. , Mayer , U. , Schinkel , A. H. , Smit , J. W. , Meijer , D. K. , Borst , P. , Nooijen , W. J. , Beijnen , J. H. and van Tellingen , O. 1997 . Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine . Proc. Natl. Acad. Sci. USA , 94 : 2031 – 2035 .
  • Speit , G. , Vasquez , M. and Hartmann , A. 2009 . The comet assay as an indicator test for germ cell genotoxicity . Mutat. Res , 681 : 3 – 12 .
  • Spracklin , D. K. , Hankins , D. C. , Fisher , J. M. , Thummel , K. E. and Kharasch , E. D. 1997 . Cytochrome P450 2E1 is the principal catalyst of human oxidative halothane metabolism in vitro . J. Pharmacol. Exp. Ther , 281 : 400 – 411 .
  • Steinert , R. E. , Frey , F. , Töpfer , A. , Drewe , J. and Beglinger , C. 2011 . Effects of carbohydrate sugars and artificial sweeteners on appetite and the secretion of gastrointestinal satiety peptides . Br. J. Nutr , 105 : 1320 – 1328 .
  • Stellman , S. D. and Garfinkel , L. 1986 . Artificial sweetener use and one-year weight change among women . Prev. Med , 15 : 195 – 202 .
  • Stellman , S. D. , Djordjevic , M. V. , Muscat , J. E. , Gong , L. , Bernstein , D. , Citron , M. L. , White , A. , Kemeny , M. , Busch , E. and Nafziger , A. N. 1998 . Relative abundance of organochlorine pesticides and polychlorinated biphenyls in adipose tissue and serum of women in Long Island, New York . Cancer Epidemiol. Biomarkers Prev , 7 : 489 – 496 .
  • Stephens , R. H. , O'Neill , C. A. , Warhurst , A. , Carlson , G. L. , Rowland , M. and Warhurst , G. 2001 . Kinetic profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia . J. Pharmacol. Exp. Ther , 296 : 584 – 591 .
  • Störmer , E. , von Moltke , L. L. , Perloff , M. D. and Greenblatt , D. J. 2001 . P-glycoprotein interactions of nefazodone and trazodone in cell culture . J. Clin. Pharmacol , 41 : 708 – 714 .
  • Störmer , E. , von Moltke , L. L. , Perloff , M. D. and Greenblatt , D. J. 2002 . Differential modulation of P-glycoprotein expression and activity by non-nucleoside HIV-1 reverse transcriptase inhibitors in cell culture . Pharm. Res , 19 : 1038 – 1045 .
  • Stouder , C. and Paoloni-Giacobino , A. 2010 . Transgenerational effects of the endocrine disruptor vinclozolin on the methylation pattern of imprinted genes in the mouse sperm . Reproduction , 139 : 373 – 379 .
  • Strolin Benedetti , M. and Dostert , P. 1994 . Induction and autoinduction properties of rifamycin derivatives: A review of animal and human studies . Environ. Health Perspect , 102 ( suppl. 9 ) : 101 – 105 .
  • Strolin Benedetti , M. , Efthymiopoulos , C. , Sassella , D. , Moro , E. and Repetto , M. 1990 . Autoinduction of rifabutin metabolism in man . Xenobiotica , 20 : 1113 – 1119 .
  • Suzuki , H. and Sugiyama , Y. 2000 . Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine . Eur. J. Pharm. Sci , 12 : 3 – 12 .
  • Svecova , L. , Vrzal , R. , Burysek , L. , Anzenbacherova , E. , Cerveny , L. , Grim , J. , Trejtnar , F. , Kunes , J. , Pour , M. , Staud , F. , Anzenbacher , P. , Dvorak , Z. and Pavek , P. 2008 . Azole antimycotics differentially affect rifampicin-induced pregnane X receptor-mediated CYP3A4 gene expression . Drug Metab. Dispos , 36 : 339 – 348 .
  • Swidsinski , A. , Loening-Baucke , V. and Herber , A. 2009 . Mucosal flora in Crohn's disease and ulcerative colitis: An overview . J. Physiol. Pharmacol , 60 ( suppl. 6 ) : 61 – 71 .
  • Swithers , S. E. 2013 . Artificial sweeteners produce the counterintuitive effect of inducing metabolic derangements . Trends Endocrinol. Metab. , 24 : 431 – 441 .
  • Swithers , S. E. and Davidson , T. L. 2008 . A role for sweet taste: Calorie predictive relations in energy regulation by rats . Behav. Neurosci , 122 : 161 – 173 .
  • Swithers , S. E. , Baker , C. R. and Davidson , T. L. 2009 . General and persistent effects of high-intensity sweeteners on body weight gain and caloric compensation in rats . Behav. Neurosci , 123 : 772 – 780 .
  • Swithers , S. E. , Laboy , A. F. , Clark , K. , Cooper , S. and Davidson , T. L. 2012 . Experience with the high-intensity sweetener saccharin impairs glucose homeostasis and GLP-1 release in rats . Behav. Brain Res , 233 : 1 – 14 .
  • Swithers , S. E. , Martin , A. A. and Davidson , T. L. 2010 . High-intensity sweeteners and energy balance . Physiol. Behav , 100 : 55 – 62 .
  • Tachibana , S. , Yoshinari , K. , Chikada , T. , Toriyabe , T. , Nagata , K. and Yamazoe , Y. 2009 . Involvement of vitamin D receptor in the intestinal induction of human ABCB1 . Drug Metab. Dispos , 37 : 1604 – 1610 .
  • Tachibana , T. , Kato , M. and Sugiyama , Y. 2012 . Prediction of nonlinear intestinal absorption of CYP3A4 and P-glycoprotein substrates from their in vitro Km values . Pharm. Res , 29 : 651 – 668 .
  • Takagi , S. , Nakajima , M. , Mohri , T. and Yokoi , T. 2008 . Post-transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4 . J. Biol. Chem , 283 : 9674 – 9680 .
  • Takano , M. , Hasegawa , R. , Fukuda , T. , Yumoto , R. , Nagai , J. and Murakami , T. 1998 . Interaction with P-glycoprotein and transport of erythromycin, midazolam and ketoconazole in Caco-2 cells . Eur. J. Pharmacol , 358 : 289 – 294 .
  • Takara , K. , Ohnishi , N. , Horibe , S. and Yokoyama , T. 2003 . Expression profiles of drug-metabolizing enzyme CYP3A and drug efflux transporter multidrug resistance 1 subfamily mRNAS in small intestine . Drug Metab. Dispos , 31 : 1235 – 1239 .
  • Takara , K. , Tanigawara , Y. , Komada , F. , Nishiguchi , K. , Sakaeda , T. and Okumura , K. 1999 . Cellular pharmacokinetic aspects of reversal effect of itraconazole on P-glycoprotein-mediated resistance of anticancer drugs . Biol. Pharm. Bull , 22 : 1355 – 1359 .
  • Tamai , I. , Saheki , A. , Saitoh , R. , Sai , Y. , Yamada , I. and Tsuji , A. 1997 . Nonlinear intestinal absorption of 5-hydroxytryptamine receptor antagonist caused by absorptive and secretory transporters . J. Pharmacol. Exp. Ther , 283 : 108 – 115 .
  • Tang , J. , Cao , Y. , Rose , R. L. , Brimfield , A. A. , Dai , D. , Goldstein , J. A. and Hodgson , E. 2001 . Metabolism of chlorpyrifos by human cytochrome P450 isoforms and human, mouse, and rat liver microsomes . Drug Metab. Dispos , 29 : 1201 – 1204 .
  • Tang , W. , Stearns , R. A. , Wang , R. W. , Chiu , S. H. and Baillie , T. A. 1999 . Roles of human hepatic cytochrome P450s 2C9 and 3A4 in the metabolic activation of diclofenac . Chem. Res. Toxicol , 12 : 192 – 199 .
  • Tao , L. , Yang , S. , Xie , M. , Kramer , P. M. and Pereira , M. A. 2000a . Hypomethylation and overexpression of c-jun and c-myc protooncogenes and increased DNA methyltransferase activity in dichloroacetic and trichloroacetic acid-promoted mouse liver tumors . Cancer Lett , 158 : 185 – 193 .
  • Tao , L. , Yang , S. , Xie , M. , Kramer , P. M. and Pereira , M. A. 2000b . Effect of trichloroethylene and its metabolites, dichloroacetic acid and trichloroacetic acid, on the methylation and expression of c-Jun and c-Myc protooncogenes in mouse liver: Prevention by methionine . Toxicol. Sci , 54 : 399 – 407 .
  • Tapaninen , T. , Neuvonen , P. J. and Niemi , M. 2010 . Rifampicin reduces the plasma concentrations and the renin-inhibiting effect of aliskiren . Eur. J. Clin. Pharmacol , 66 : 497 – 502 .
  • Tassaneeyakul , W. , Birkett , D. J. and Miners , J. O. 1998 . Inhibition of human hepatic cytochrome P4502E1 by azole antifungals, CNS-active drugs and non-steroidal anti-inflammatory agents . Xenobiotica , 28 : 293 – 301 .
  • Teitelbaum , J. E. and Walker , W. A. 2002 . Nutritional impact of pre- and probiotics as protective gastrointestinal organisms . Annu. Rev. Nutr , 22 : 107 – 138 .
  • Thomas , G. 2007 . Medicinal chemistry: An introduction , Vol. 83 , Chichester , UK : John Wiley & Sons . 2nded
  • Thummel , K. E. , Kunze , K. L. and Shen , D. D. 1997 . Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction . Adv. Drug. Deliv. Rev , 27 : 99 – 127 .
  • Thummel , K. E. , O'Shea , D. , Paine , M. F. , Shen , D. D. , Kunze , K. L. , Perkins , J. D. and Wilkinson , G. R. 1996 . Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism . Clin. Pharmacol. Ther , 59 : 491 – 502 .
  • Tian , R. , Koyabu , N. , Morimoto , S. , Shoyama , Y. , Ohtani , H. and Sawada , Y. 2005 . Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line . Drug Metab. Dispos , 33 : 547 – 554 .
  • Tilghman , S. L. , Bratton , M. R. , Segar , H. C. , Martin , E. C. , Rhodes , L. V. , Li , M. , McLachlan , J. A. , Wiese , T. E. , Nephew , K. P. and Burow , M. E. 2012 . Endocrine disruptor regulation of microRNA expression in breast carcinoma cells . PLoS One , 7 : e32754
  • Tokairin , T. , Fukasawa , T. , Yasui-Furukori , N. , Aoshima , T. , Suzuki , A. , Inoue , Y. , Tateishi , T. and Otani , K. 2005 . Inhibition of the metabolism of brotizolam by erythromycin in humans: In vivo evidence for the involvement of CYP3A4 in brotizolam metabolism . Br. J. Clin. Pharmacol , 60 : 172 – 175 .
  • Tolle-Sander , S. , Rautio , J. , Wring , S. , Polli , J. W. and Polli , J. E. 2003 . Midazolam exhibits characteristics of a highly permeable P-glycoprotein substrate . Pharm. Res , 20 : 757 – 764 .
  • Tomaszewski , P. , Kubiak-Tomaszewska , G. and Pachecka , J. 2008 . Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. II. Participation of CYP isoenzymes in the metabolism of endogenous substances and drugs . Acta Pol. Pharm , 65 : 307 – 318 .
  • Topping , D. L. and Clifton , P. M. 2001 . Short-chain fatty acids and human colonic function: Roles of resistant starch and nonstarch polysaccharides . Physiol. Rev , 81 : 1031 – 1064 .
  • Tritscher , A. M. 2004 . Human health risk assessment of processing-related compounds in food . Toxicol Lett , 149 : 177 – 186 .
  • Turnbaugh , P. J. and Gordon , J. I. 2009 . The core gut microbiome, energy balance and obesity . J. Physiol , 587 : 4153 – 4158 .
  • Turnbaugh , P. J. , Ley , R. E. , Mahowald , M. A. , Magrini , V. , Mardis , E. R. and Gordon , J. I. 2006 . An obesity-associated gut microbiome with increased capacity for energy harvest . Nature , 444 : 1027 – 1031 .
  • Ueyama , J. , Nadai , M. , Kanazawa , H. , Iwase , M. , Nakayama , H. , Hashimoto , K. , Yokoi , T. , Baba , K. , Takagi , K. , Takagi , K. and Hasegawa , T. 2005 . Endotoxin from various gram-negative bacteria has differential effects on function of hepatic cytochrome P450 and drug transporters . Eur. J. Pharmacol , 510 : 127 – 134 .
  • U.S. Food and Drug Administration. 1998. Food additives permitted for direct addition to food for human consumption; sucralose. 21CFR Part 172 [Docket No. 87F-0086]. Fed. Reg. 63(64): 16417–16433accessed February 6, 2013 http://www.gpo.gov/fdsys/pkg/FR-1998-04-03/pdf/98-8750.pdf (http://www.gpo.gov/fdsys/pkg/FR-1998-04-03/pdf/98-8750.pdf)
  • U.S. Food and Drug Administration. 1999. Food additives permitted for direct addition to food for human consumption: Sucralose. 21CFR Part 172 [Docket No. 99F-0001]. Fed. Reg. 64(155): 43908–43909accessed February 6, 2013 http://www.fda.gov/ohrms/dockets/98fr/081299b.pdf (http://www.fda.gov/ohrms/dockets/98fr/081299b.pdf)
  • U.S. Food and Drug Administration. 2007. Guidance for industry and other stakeholders. Toxicological principles for the safety assessment of food ingredients. Redbook 2000. Revised July 2007accessed February 6, 2013 http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredientsandPackaging/Redbook/default.htm (http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredientsandPackaging/Redbook/default.htm)
  • U.S. Food and Drug Administration. 2011. Drug development and drug interactions: Table of substrates, inhibitors and inducersaccessed February 6, 2013 http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/DrugInteractionsLabeling/ucm093664.htm (http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/DrugInteractionsLabeling/ucm093664.htm)
  • U.S. Food and Drug Administration. 2012. Everything Added to Food in the United States (EAFUS)accessed February 6, 2013 http://www.accessdata.fda.gov/scripts/fcn/fcnNavigation.cfm?filter=121746-18-7&sortColumn=36%28%25%3AH!52ED0!AP%2C%2C0M%2F5Q9Q%2CF%40++%0D%0A&rpt=eafusListing (http://www.accessdata.fda.gov/scripts/fcn/fcnNavigation.cfm?filter=121746-18-7&sortColumn=36%28%25%3AH!52ED0!AP%2C%2C0M%2F5Q9Q%2CF%40++%0D%0A&rpt=eafusListing)
  • van Breemen , R. B. and Li , Y. 2005 . Caco-2 cell permeability assays to measure drug absorption . Expert Opin. Drug Metab. Toxicol , 1 : 175 – 185 .
  • van de Poll , M. E. , Relling , M. V. , Schuetz , E. G. , Harrison , P. L. , Hughes , W. and Flynn , P. M. 2001 . The effect of atovaquone on etoposide pharmacokinetics in children with acute lymphoblastic leukemia . Cancer Chemother. Pharmacol , 47 : 467 – 472 .
  • van Herwaarden , A. E. , van Waterschoot , R. A. and Schinkel , A. H. 2009 . How important is intestinal cytochrome P450 3A metabolism? . Trends Pharmacol. Sci , 30 : 223 – 227 .
  • Vasiliu , O. , Cameron , L. , Gardiner , J. , Deguire , P. and Karmaus , W. 2006 . Polybrominated biphenyls, polychlorinated biphenyls, body weight, and incidence of adult-onset diabetes mellitus . Epidemiology , 17 : 352 – 359 .
  • Venkatakrishnan , K. , von Moltke , L. L. , Duan , S. X. , Fleishaker , J. C. , Shader , R. I. and Greenblatt , D. J. 1998 . Kinetic characterization and identification of the enzymes responsible for the hepatic biotransformation of adinazolam and N-desmethyladinazolam in man . J. Pharm. Pharmacol , 50 : 265 – 274 .
  • Villena , J. , Racedo , S. , Agüero , G. , Bru , E. , Medina , M. and Alvarez , S. 2005 . Lactobacillus casei improves resistance to pneumococcal respiratory infection in malnourished mice . J. Nutr , 135 : 1462 – 1469 .
  • Villeneuve , D. C. , Van Logten , M. J. , Den Tonkelaar , E. M. , Greve , P. A. , Vos , J. G. , Speijers , G. J. A. and Van Esch , G. J. 1977 . Effect of food deprivation on low level hexachlorobenzene exposure in rats . Sci. Total Environ , 8 : 179 – 186 .
  • von Moltke , L. L. , Greenblatt , D. J. , Harmatz , J. S. , Duan , S. X. , Harrel , L. M. , Cotreau-Bibbo , M. M. , Pritchard , G. A. , Wright , C. E. and Shader , R. I. 1996 . Triazolam biotransformation by human liver microsomes in vitro: Effects of metabolic inhibitors and clinical confirmation of a predicted interaction with ketoconazole . J. Pharmacol. Exp. Ther , 276 : 370 – 379 .
  • von Richter , O. , Greiner , B. , Fromm , M. F. , Fraser , R. , Omari , T. , Barclay , M. L. , Dent , J , Somogyi , A. A. and Eichelbaum , M. 2001 . Determination of in vivo absorption, metabolism and transport of drugs by the human intestinal wall and liver with a novel perfusion technique . Clin. Pharmacol. Ther , 70 : 217 – 227 .
  • Voulgaridou , G. P. , Anestopoulos , I. , Franco , R. , Panayiotidis , M. I. and Pappa , A. 2011 . DNA damage induced by endogenous aldehydes: Current state of knowledge . Mutat. Res , 711 : 13 – 27 .
  • Vucetic , Z. , Kimmel , J. , Totoki , K. , Hollenbeck , E. and Reyes , T. M. 2010 . Maternal high-fat diet alters methylation and gene expression of dopamine and opioid-related genes . Endocrinology , 151 : 4756 – 4764 .
  • Waade , R. B. , Christensen , H. , Rudberg , I. , Refsum , H. and Hermann , M. 2009 . Influence of comedication on serum concentrations of aripiprazole and dehydroaripiprazole . Ther. Drug Monit , 31 : 233 – 238 .
  • Wacher , V. J. , Salphati , L. and Benet , L. Z. 2001 . Active secretion and enterocytic drug metabolism barriers to drug absorption . Adv. Drug Deliv. Rev , 46 : 89 – 102 .
  • Wacher , V. J. , Wu , C. Y. and Benet , L. Z. 1995 . Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: Implications for drug delivery and activity in cancer chemotherapy . Mol. Carcinogen , 13 : 129 – 134 .
  • Wagstaff , A. J. and Keating , G. M. 2006 . Anagrelide: A review of its use in the management of essential thrombocythaemia . Drugs , 66 : 111 – 131 .
  • Walsky , R. L. , Gaman , E. A. and Obach , R. S. 2005a . Examination of 209 drugs for inhibition of cytochrome P450 2C8 . J. Clin. Pharmacol , 45 : 68 – 78 .
  • Walsky , R. L. , Obach , R. S. , Gaman , E. A. , Gleeson , J. P. and Proctor , W. R. 2005b . Selective inhibition of human cytochrome P4502C8 by montelukast . Drug Metab. Dispos , 33 : 413 – 418 .
  • Wandel , C. , Kim , R. , Wood , M. and Wood , A. 2002 . Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P-glycoprotein . Anesthesiology , 96 : 913 – 920 .
  • Wang , E. J. , Casciano , C. N. , Clement , R. P. and Johnson , W. W. 2001 . Active transport of fluorescent P-glycoprotein substrates: Evaluation as markers and interaction with inhibitors . Biochem. Biophys. Res. Commun , 289 : 580 – 585 .
  • Wang , E. J. , Lew , K. , Casciano , C. N. , Clement , R. P. and Johnson , W. W. 2002 . Interaction of common azole antifungals with P glycoprotein . Antimicrob. Agents Chemother , 46 : 160 – 165 .
  • Wang , J. S. , Zhu , H. J. , Gibson , B. B. , Markowitz , J. S. , Donovan , J. L. and DeVane , C. L. 2008 . Sertraline and its metabolite desmethylsertraline, but not bupropion or its three major metabolites, have high affinity for P-glycoprotein . Biol. Pharm. Bull , 31 : 231 – 234 .
  • Wang , K. Y. , Li , S. N. , Liu , C. S. , Perng , D. S. , Su , Y. C. , Wu , D. C. , Jan , C. M. , Lai , C. H. , Wang , T. N. and Wang , W. M. 2004 . Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized . Helicobacter pylori. Am. J. Clin. Nutr , 80 : 737 – 741 .
  • Ward , B. A. , Morocho , A. , Kandil , A. , Galinsky , R. E. , Flockhart , D. A. and Desta , Z. 2004 . Characterization of human cytochrome P450 enzymes catalyzing domperidone N-dealkylation and hydroxylation in vitro . Br. J. Clin. Pharmacol , 58 : 277 – 287 .
  • Warner , M. and Gustafsson , J. A. 1994 . Effect of ethanol on cytochrome P450 in the rat brain . Proc. Natl. Acad. Sci. USA , 91 : 1019 – 1023 .
  • Warwick , Z. S. and Schiffman , S. S. 1991 . Flavor-calorie relationships: Effect on weight gain in rats . Physiol. Behav , 50 : 465 – 470 .
  • Watkins , P. B. 1992 . Drug metabolism by cytochromes P450 in the liver and small bowel . Gastroenterol. Clin. North Am , 21 : 511 – 526 .
  • Watkins , P. B. 1997 . The barrier function of CYP3A4 and P-glycoprotein in the small bowel . Adv. Drug Deliv. Rev , 27 : 161 – 170 .
  • Watkins , P. B. , Wrighton , S. A. , Schuetz , E. G. , Molowa , D. T. and Guzelian , P. S. 1987 . Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man . J. Clin. Invest , 80 : 1029 – 1036 .
  • Weaver , R. J. , Webster , D. , Melvin , W. T. , Dickins , M. and Burke , M. D. 1993 . Human cytochrome P4502C metabolism . Br. J. Clin. Pharmacol , 36 : 167P
  • Weisbrod , A. V. , Shea , D. , Moore , M. J. and Stegeman , J. J. 2001 . Species, tissue and gender-related organochlorine bioaccumulation in white-sided dolphins, pilot whales and their common prey in the northwest Atlantic . Mar. Environ. Res , 51 : 29 – 50 .
  • Weiss , J. , Dormann , S. M. , Martin-Facklam , M. , Kerpen , C. J. , Ketabi-Kiyanvash , N. and Haefeli , W. E. 2003 . Inhibition of P-glycoprotein by newer antidepressants . J. Pharmacol. Exp. Ther , 305 : 197 – 204 .
  • Wen , B. , Ma , L. , Rodrigues , A. D. and Zhu , M. 2008 . Detection of novel reactive metabolites of trazodone: Evidence for CYP2D6-mediated bioactivation of m-chlorophenylpiperazine . Drug Metab. Dispos , 36 : 841 – 850 .
  • Wengreen , H. J. and Moncur , C. 2009 . Change in diet, physical activity, and body weight among young-adults during the transition from high school to college . Nutr. J , 8 : 32
  • Wenner , M. 2009 . A new kind of drug target . Sci. Am , 301 : 70 – 74 . 76
  • Westphal , K. , Weinbrenner , A. , Zschiesche , M. , Franke , G. , Knoke , M. , Oertel , R. , Fritz , P. , von Richter , O. , Warzok , R. , Hachenberg , T. , Kauffmann , H. M. , Schrenk , D. , Terhaag , B. , Kroemer , H. K. and Siegmund , W. 2000 . Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: A new type of drug/drug interaction . Clin. Pharmacol. Ther , 68 : 345 – 355 .
  • Wiklund , A. K. , Breitholtz , M. , Bengtsson , B. E. and Adolfsson-Erici , M. 2012 . Sucralose—An ecotoxicological challenger? . Chemosphere , 86 : 50 – 55 .
  • Wood , S. G. , John , B. A. and Hawkins , D. R. 2000 . The pharmacokinetics and metabolism of sucralose in the dog . Food Chem. Toxicol , 38 ( suppl. 2 ) : S99 – S106 .
  • Woodmansey , E. J. 2007 . Intestinal bacteria and ageing . J. Appl. Microbiol , 102 : 1178 – 1186 .
  • Wootten , D. , Savage , E. E. , Valant , C. , May , L. T , Sloop , K. W. , Ficorilli , J. , Showalter , A. D. , Willard , F. S. , Christopoulos , A. and Sexton , P. M. 2012 . Allosteric modulation of endogenous metabolites as an avenue for drug discovery . Mol. Pharmacol , 82 : 281 – 290 .
  • World Health Organization. 1989. Trichlorogalactosucrose. In Toxicological evaluation of certain food additives and contaminants. WHO Food Additives Series, no. 24. Cambridge University Press, 1989, no. 655accessed February 6, 2013 http://www.inchem.org/documents/jecfa/jecmono/v024je05.htm (http://www.inchem.org/documents/jecfa/jecmono/v024je05.htm)
  • World Health Organization. 1991. Evaluation of certain food additives and contaminants, 21–23. Thirty-seventh report of the Joint FAO/WHO Expert Committee on Food Additives. WHO Technical Report Series 806. World Health Organization, Geneva, Switzerlandaccessed February 6, 2013 whqlibdoc.who.int/trs/WHO_TRS_806.pdf (http://whqlibdoc.who.int/trs/WHO_TRS_806.pdf)
  • World Health Organization. 2002. 3-Chloro-1,2-propanediol. In Safety evaluation of certain food additives and contaminants. WHO Food Additives Series 48.accessed February 6, 2013 http://www.inchem.org/documents/jecfa/jecmono/v48je18.htm (http://www.inchem.org/documents/jecfa/jecmono/v48je18.htm)
  • World Health Organization. 2003. Adherence to long-term therapies: Evidence for action. Geneva (Switzerland): World Health Organisationaccessed February 6, 2013 http://www.who.int/chp/knowledge/publications/adherence_full_report.pdf (http://www.who.int/chp/knowledge/publications/adherence_full_report.pdf)
  • World Health Organization. 2012. Safety evaluation of certain food additives and contaminants, 291–298. WHO Food Additives Series 67accessed February 6, 2013 http://www.who.int, 9789241660679_eng.pdf (http://www.who.int, 9789241660679_eng.pdf)
  • World Health Organization. 2013. Obesity and overweight. Fact sheet number 311,□updated March 2013 http://www.who.int/mediacentre/factsheets/fs311/en (http://www.who.int/mediacentre/factsheets/fs311/en)
  • Wu , J. , Dong , S. , Liu , G. , Zhang , B. and Zheng , M. 2011 . Cooking process: A new source of unintentionally produced dioxins? . J. Agric. Food Chem , 59 : 5444 – 5449 .
  • Xie , R. , Tan , L. H. , Polasek , E. C. , Hong , C. , Teillol-Foo , M. , Gordi , T. , Sharma , A. , Nickens , D. J. , Arakawa , T. , Knuth , D. W. and Antal , E. J. 2005 . CYP3A and P-glycoprotein activity induction with St. John's Wort in healthy volunteers from 6 ethnic populations . J. Clin. Pharmacol , 45 : 352 – 356 .
  • Yanagiba , Y. , Ito , Y. , Kamijima , M. , Gonzalez , F. J. and Nakajima , T. 2009 . Octachlorostyrene induces cytochrome P450, UDP-glucuronosyltransferase, and sulfotransferase via the aryl hydrocarbon receptor and constitutive androstane receptor . Toxicol. Sci , 111 : 19 – 26 .
  • Yang , Q. 2010 . Gain weight by "going diet?" Artificial sweeteners and the neurobiology of sugar cravings: Neuroscience 2010 . Yale J. Biol. Med , 83 : 101 – 108 .
  • Yang , T. H. , Tian , L. Y. , Shang , H. F. , Cheng , X. W. , Geng , J. , Chen , L. and Zhou , D. 2009 . Suppression of the multidrug transporter P-glycoprotein using RNA interference in cultured rat astrocytes induced by coriaria lactone . Neurol. Res , 31 : 1084 – 1091 .
  • Yasuda , K. , Ranade , A. , Venkataramanan , R. , Strom , S. , Chupka , J. , Ekins , S. , Schuetz , E. and Bachmann , K. 2008 . A comprehensive in vitro and in silico analysis of antibiotics that activate pregnane X receptor and induce CYP3A4 in liver and intestine . Drug Metab. Dispos , 36 : 1689 – 1697 .
  • Yasuda , S. U. , Zannikos , P. , Young , A. E. , Fried , K. M. , Wainer , I. W. and Woosley , R. L. 2002 . The roles of CYP2D6 and stereoselectivity in the clinical pharmacokinetics of chlorpheniramine . Br. J. Clin. Pharmacol , 53 : 519 – 525 .
  • Yasui , N. , Otani , K. , Kaneko , S. , Ohkubo , T. , Osanai , T. , Sugawara , K. , Chiba , K. and Ishizaki , T. 1996 . A kinetic and dynamic study of oral alprazolam with and without erythromycin in humans: In vivo evidence for the involvement of CYP3A4 in alprazolam metabolism . Clin. Pharmacol. Ther , 59 : 514 – 519 .
  • Yoshii , K. , Kobayashi , K. , Tsumuji , M. , Tani , M. , Shimada , N. and Chiba , K. 2000 . Identification of human cytochrome P450 isoforms involved in the 7-hydroxylation of chlorpromazine by human liver microsomes . Life Sci , 67 : 175 – 184 .
  • Young , D. A. and Bowen , W. H. 1990 . The influence of sucralose on bacterial metabolism . J. Dent. Res , 69 : 1480 – 1484 .
  • Yue , J. , Miksys , S. , Hoffmann , E. and Tyndale , R. F. 2008 . Chronic nicotine treatment induces rat CYP2D in the brain but not in the liver: An investigation of induction and time course . J. Psychiat. Neurosci , 33 : 54 – 63 .
  • Zama , A. M. and Uzumcu , M. 2009 . Fetal and neonatal exposure to the endocrine disruptor methoxychlor causes epigenetic alterations in adult ovarian genes . Endocrinology , 150 : 4681 – 4691 .
  • Zama , A. M. and Uzumcu , M. 2010 . Epigenetic effects of endocrine-disrupting chemicals on female reproduction: An ovarian perspective . Front. Neuroendocrinol , 31 : 420 – 439 .
  • Zhang , F. , Klebansky , B. , Fine , R. M. , Liu , H. , Xu , H. , Servant , G. , Zoller , M. , Tachdjian , C. and Li , X. 2010 . Molecular mechanism of the sweet taste enhancers . Proc. Natl. Acad. Sci. USA , 107 : 4752 – 4757 .
  • Zhang , Q. Y. , Dunbar , D. , Ostrowska , A. , Zeisloft , S. , Yang , J. and Kaminsky , L. S. 1999 . Characterization of human small intestinal cytochromes P-450 . Drug Metab. Dispos , 27 : 804 – 809 .
  • Zhang , W. , Ramamoorthy , Y. , Kilicarslan , T. , Nolte , H. , Tyndale , R. F. and Sellers , E. M. 2002 . Inhibition of cytochromes P450 by antifungal imidazole derivatives . Drug Metab. Dispos , 30 : 314 – 318 .
  • Zhang , Y. F. , Chen , X. Y. , Guo , Y. J. , Si , D. Y. , Zhou , H. and Zhong , D. F. 2005 . Impact of cytochrome P450 CYP2C9 variant allele CYP2C9 * 3 on the pharmacokinetics of glibenclamide and lornoxicam in Chinese subjects . Yao Xue Xue Bao , 40 : 796 – 799 .
  • Zhou , S. F. and Lai , X. 2008 . An update on clinical drug interactions with the herbal antidepressant St. John's wort . Curr. Drug Metab , 9 : 394 – 409 .
  • Zhou , S. F. , Zhou , Z. W. , Yang , L. P. and Cai , J. P. 2009 . Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development . Curr. Med. Chem , 16 : 3480 – 3675 .
  • Zhu , M. , Kaul , S. , Nandy , P. , Grasela , D. M. and Pfister , M. 2009 . Model-based approach to characterize efavirenz autoinduction and concurrent enzyme induction with carbamazepine . Antimicrob. Agents Chemother , 53 : 2346 – 2353 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.